<SEC-DOCUMENT>0001493152-25-020135.txt : 20251030
<SEC-HEADER>0001493152-25-020135.hdr.sgml : 20251030
<ACCEPTANCE-DATETIME>20251030070039
ACCESSION NUMBER:		0001493152-25-020135
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251030
DATE AS OF CHANGE:		20251030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AmpliTech Group, Inc.
		CENTRAL INDEX KEY:			0001518461
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				274566352
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288863
		FILM NUMBER:		251432136

	BUSINESS ADDRESS:	
		STREET 1:		155 PLANT AVENUE
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788
		BUSINESS PHONE:		631-521-7831

	MAIL ADDRESS:	
		STREET 1:		155 PLANT AVENUE
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAYVIEW ACQUISITION CORP
		DATE OF NAME CHANGE:	20110418
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
    SUPPLEMENT</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Pursuant to Rule 424(b)(5)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
    Prospectus Dated August 4, 2025) </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
    No. 333-288863</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="form424b5_004.jpg" ALT="" style="width:350px"></P>

<P STYLE="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferable
Unit Subscription Right to Purchase up to 8,000,000 Units,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit Consisting of One Share of Common Stock,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
Series A Right, and One Series B Right,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">up to 8,000,000
Shares of Common Stock Upon Exercise of Unit Subscription Rights,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
up to 16,000,000 Shares of Common Stock Issuable Upon Exercise of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Series A Rights and Series B Rights;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">up
to a Total of 24,000,000 Shares of Common</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
in the Aggregate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are distributing in the form of a dividend, at no charge, transferable unit subscription rights (the &ldquo;Unit
Subscription Rights&rdquo;) entitling holders of our common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), and
certain eligible warrantholders (pursuant to contractual rights) (&ldquo;Eligible Warrantholders&rdquo;) as of the record date of
5:00 p.m., Eastern time, on November 10, 2025 (the &ldquo;Record Date&rdquo;), to purchase units (&ldquo;Units&rdquo;) at a
subscription price of $4.00 per Unit (&ldquo;Unit Subscription Price&rdquo;). Each Unit will consist of one share of Common
Stock, one Series A right to purchase one share of Common Stock (&ldquo;Series A Right&rdquo;), and one Series B right to
purchase one share of Common Stock (&ldquo;Series B Right&rdquo; and, together with the Series A Right, collectively the &ldquo;Series
Rights&rdquo; and together with the Unit Subscription Rights, collectively, the &ldquo;Rights&rdquo;). The Common Stock, Series
A Right and Series B Right comprising the Units will separate upon the closing of the Unit Subscription Rights offering (the &ldquo;Unit
Subscription Rights Offering&rdquo;) and will be issued separately but may only be purchased as a Unit. The Units will not be
issued or traded as a separate security. We refer to the offering of the Unit Subscription Rights and the Series
Rights as the &ldquo;offering&rdquo; or the &ldquo;Rights Offering.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
will receive two (2) Unit Subscription Rights for each share of our Common Stock beneficially owned or acquirable upon exercise
of their eligible warrants as of the Record Date. As part of each Unit Subscription Right, you will have the right, which
we refer to as your basic subscription right, to purchase one Unit subject to aggregate Unit issuance limitations and pro rata
adjustments. If you exercise your basic subscription right in full, you will also have the right, referred to as the
oversubscription privilege, to subscribe for additional Units for which other rights holders do not subscribe. Once made, all
exercises of the Unit Subscription Rights being distributed and the Series Rights comprising the Units are irrevocable.
See &ldquo;The Rights Offering &mdash; Limitation on the Purchase of Units&rdquo; for a description of certain limitations on purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Unit Subscription Rights
will expire if not exercised by 5:00 p.m., Eastern time, on December 10, 2025, unless we extend or terminate the Unit
Subscription Rights Offering. We may extend the Unit Subscription Rights Offering for one or more additional periods in
our sole discretion not to exceed 30 days in the aggregate from the expiration date. We will announce any extension in a
press release issued no later than 9:00 a.m., Eastern time, on the business day after the most recently announced expiration
date.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Series Rights are issuable after
the expiration of the Unit Subscription Rights. The Series Rights are exercisable commencing on their date of issuance until their
respective expiration dates and the exercise price of the Series Rights shall be equal to (i) in the case of the Series
A Rights, $5.00 per share; and (ii) in the case of the Series B Rights, $6.00 per share. The Series Rights will
be transferable until they expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We have engaged VStock Transfer,
LLC to serve as the subscription agent (the &ldquo;Subscription Agent&rdquo;) for the Unit Subscription Rights and the
Series Rights. We have also engaged Citizens Bank, N.A., a national banking association acting through its Institutional Services
Group located at 1 Citizens Drive, Riverside, RI 02915 to serve as escrow agent (the &ldquo;Escrow Agent&rdquo;) to hold in
escrow the funds we receive from subscribers for the Unit Subscription Rights (until the respective closings, expiration or cancellation
of the Rights Offering) and the Series Rights. If you want to exercise your Rights, you must submit (i) your subscription
documents to our Subscription Agent; and (ii) payment to the Escrow Agent before the applicable expiration date. If you
want to participate in the offering and you hold shares through your broker, dealer, bank or other nominee, you should promptly
contact your broker, dealer, bank or other nominee and submit your subscription documents and payment in accordance with the instructions
and within the time periods provided by your broker, dealer, bank or other nominee.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The maximum number of our Units available
for issuance in this offering is 8,000,000 Units, and the maximum number of shares issuable in the offering is 24,000,000 shares of Common
Stock, which includes up to 8,000,000 shares of Common Stock issuable upon exercise of each of the Rights issuable in this Rights
Offering. If more than 8,000,000 basic subscription rights are subscribed pursuant to the Unit Subscription Rights,
we will allocate Units to subscribers on a pro-rata basis to fill basic subscription rights based on the total number of basic subscription
rights subscribed by each subscriber and no subscriptions pursuant to the oversubscription privilege will be fulfilled. Any
excess payments will be returned without interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the date of this prospectus supplement, we were subject to General Instruction I.B.6 of Form S-3 as a result of our public float being
less than $75.0 million, which limited the maximum amount of Common Stock we could sell. On September 22, 2025, our public float increased
above $75.0 million and, as a result, we are not subject to the limitations contained in General Instruction I.B.6 of Form S-3 as of
the date of this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed on The Nasdaq
Capital Market under the symbol &ldquo;AMPG.&rdquo; The last reported sale price of our Common Stock on October 29, 2025 was $3.64
per share. We do not intend to apply for listing or quotation of the Unit Subscription Rights or the Series Rights on any securities
exchange or trading market.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves significant risks. See &ldquo;Risk Factors&rdquo; beginning on page S-21 of this prospectus supplement and in the
documents incorporated by reference in this prospectus supplement for a discussion of the factors you should consider before
deciding to exercise the Unit Subscription Rights to purchase the Units, the respective Series Rights and the Common
Stock underlying the Units and the Series Rights. We and our board of directors are not making any recommendation regarding the
exercise of your Rights.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We have engaged Moody Capital Solutions,
Inc. (&ldquo;Moody Capital&rdquo;) to act as dealer-manager for this offering and we do not need to receive any minimum amount of
proceeds in order to close on the offering. This offering is being conducted on a best-efforts basis, and we do not need to receive
any minimum amount of proceeds in order to complete this offering.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per Unit</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit Subscription Price<SUP>(1)(2)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">4.000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">32,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealer-manager fees and expenses<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.280</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,240,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds to us, before expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.720</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">29,760,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)
</SUP>Assumes the sale of all offered Units and no exercise of the Series Rights included in the Units, and based on the 8,000,000
maximum number of Units available for issuance in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)
</SUP>The Company may raise a maximum of $120,000,000 assuming the sale of all offered Units and full exercise of the Series
A Rights at $5.00 per share, and Series B Rights at $6.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(3) </SUP>We
have agreed to pay Moody Capital, a cash fee equal to 7.0% of the proceeds of the offering from the exercise of the Unit
Subscription Rights and Series Rights, and an out-of-pocket accountable expense allowance not to exceed $35,000 (the
&ldquo;Accountable Expense Allowance&rdquo;); provided however, if we raise (i) more than $10 million but less than $20 million, we
have agreed to pay Moody Capital a cash fee equal to 6% and the Accountable Expense Allowance and (ii) less than $10 million, we
have agreed to pay Moody Capital a cash fee equal to 5% and the Accountable Expense Allowance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal
offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions or need further information about this offering, please call MacKenzie Partners Inc., the information agent
for this offering at telephone (212) 929-5500 (bankers and brokers) or (800) 322-2885 (all others) or by email at AMPG@mackenziepartners.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealer-Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form424b5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus supplement is  October 30, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus Supplement</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#incorporate"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION
    BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">S-2</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#forword"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>S-3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONS AND ANSWERS RELATING TO THIS OFFERING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE RIGHTS OFFERING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-16</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_005">DESCRIPTION OF SERIES RIGHTS</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#S_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-35</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">INFORMATION WE INCORPORATE BY REFERENCE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">AMPLITECH GROUP, INC.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">DESCRIPTION OF WARRANTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">DESCRIPTION OF RIGHTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">DESCRIPTION OF UNITS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><A HREF="#a_015">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_001"></A>ABOUT
THIS PROSPECTUS SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying base prospectus form a part of a registration statement on Form S-3 (File No. 333-288863)
utilizing a shelf registration process relating to the securities described in this prospectus supplement, which registration statement
was declared effective on August 4, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document consists of two parts. The first part is the prospectus supplement, including the documents incorporated by reference herein,
which describes the specific terms of this offering. The second part, the accompanying prospectus, including the documents incorporated
by reference therein, provides more general information. In general, when we refer only to the prospectus, we are referring to both parts
of this document combined. Before you invest, you should carefully read this prospectus supplement, the accompanying prospectus, all
information incorporated by reference herein and therein, as well as the additional information described under the heading &ldquo;Where
You Can Find More Information.&rdquo; These documents contain information you should carefully consider when deciding whether to invest
in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement may add, update or change information contained in the accompanying prospectus. To the extent there is a conflict
between the information contained in this prospectus supplement and the accompanying prospectus, you should rely on information contained
in this prospectus supplement, provided that if any statement in, or incorporated by reference into, one of these documents is inconsistent
with a statement in another document having a later date, the statement in the document having the later date modifies or supersedes
the earlier statement. Any statement so modified will be deemed to constitute a part of this prospectus supplement only as so modified,
and any statement so superseded will be deemed not to constitute a part of this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus supplement, the accompanying prospectus, any document incorporated by
reference herein or therein, or any free writing prospectuses we may provide to you in connection with this offering. Neither we nor
Moody Capital have authorized anyone to provide you with any different information. We take no responsibility for and can provide no
assurance as to the reliability of, any other information that others may provide to you. The information contained in this prospectus
supplement, the accompanying prospectus, and in the documents incorporated by reference herein or therein is accurate only as of the
date such information is presented. Our business, financial condition, results of operations and prospects may have changed since that
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities
other than the Unit Subscription Rights, Units, Common Stock and Series Rights to which it relates (collectively, the &ldquo;Securities&rdquo;),
nor does this prospectus supplement and the accompanying prospectus constitute an offer to sell or the solicitation of an offer to buy
Securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that
is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for
the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant
to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of our affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly indicated or the context otherwise requires, we use the terms &ldquo;AmpliTech,&rdquo; the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; or similar references to refer to AmpliTech Group, Inc. together with any subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed our registration statement on Form S-3 with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) under the Securities
Act of 1933, as amended, or the Securities Act. We also file annual, quarterly and current reports, proxy statements and other information
with the SEC. You can read and copy any document that we file with the SEC, including the registration statement and exhibits to the
registration statement, over the internet at the SEC&rsquo;s website at <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;)
and we are required to file reports, proxy statements and other information with the SEC. These reports, proxy statements, and other
information are available for inspection and copying at the SEC&rsquo;s website referred to above. These documents may also be accessed
on our web site at www.amplitechgroup.com. Information contained on our web site is not incorporated by reference into this prospectus
supplement or the accompanying prospectus and you should not consider information contained on our web site to be part of this prospectus
supplement or the accompanying prospectus. Information contained on or accessible through our website is not a part of this prospectus
supplement, and the inclusion of our website address in this prospectus supplement is an inactive textual reference only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying prospectus are part of a registration statement filed with the SEC and do not contain all
of the information in the registration statement. The full registration statement may be obtained from the SEC or us as indicated above.
Other documents establishing the terms of the securities offered are filed as exhibits to the registration statement or will be filed
through an amendment to our registration statement on Form S-3 or under cover of a Current Report on Form 8-K and incorporated into this
prospectus supplement by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="incorporate"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
WE INCORPORATED BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to &ldquo;incorporate by reference&rdquo; into this prospectus supplement and the accompanying prospectus the information
we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated
by reference is considered to be part of this prospectus supplement and the accompanying prospectus. Any statement contained herein or
in a document incorporated or deemed to be incorporated by reference into this document will be deemed to be modified or superseded for
purposes of the document to the extent that a statement contained in this document or any other subsequently filed document that is deemed
to be incorporated by reference into this document modifies or supersedes the statement. We incorporate by reference in this prospectus
supplement and the accompanying prospectus the following information (other than, in each case, documents or information deemed to have
been furnished and not filed in accordance with SEC rules):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; our
Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001715/form10-k.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the fiscal year ended December 31, 2024 (filed with the SEC on March 31, 2025);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; our
Quarterly Report on Form 10-Q for the quarterly period ended <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225010523/form10-q.htm" STYLE="-sec-extract: exhibit">March 31, 2025</A> filed with the SEC on May 15, 2025 and for the quarterly
period ended <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000149315225011972/form10-q.htm" STYLE="-sec-extract: exhibit">June 30, 2025</A> filed with the SEC on August 14, 2025;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; our
Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000149315225002942/form8-k.htm" STYLE="-sec-extract: exhibit">January 21, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225000178/form8-k.htm" STYLE="-sec-extract: exhibit">March 24, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001724/form8-k.htm" STYLE="-sec-extract: exhibit">March 31, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225007751/form8-k.htm" STYLE="-sec-extract: exhibit">April 30, 2025</A>; and <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225020599/form8-k.htm" STYLE="-sec-extract: exhibit">July 22, 2025</A>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; our
Proxy Statement on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1518461/000149315225018225/formdef14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A</A> filed with the SEC on October 16, 2025;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; our
F<A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000147793221000843/ampg_8a12b.htm" STYLE="-sec-extract: exhibit">orm 8-A12B</A>, filed with the SEC on February 16, 2021; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
description of the securities of the Company contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001715/ex4-4.htm" STYLE="-sec-extract: exhibit">Exhibit 4.4</A> of our Annual Report on Form 10-K for the year ended December 31,
2024 (filed with the SEC on March 31, 2025).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reports and other documents that we subsequently file with the SEC (excluding any portions of such documents that have been &ldquo;furnished
to&rdquo; but not &ldquo;filed with&rdquo; the SEC) pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date
of this prospectus supplement and before the later of (1) the completion of the offering of our Securities pursuant to this prospectus
supplement and (2) the date we stop offering our Securities pursuant to this prospectus supplement, will be deemed to be incorporated
by reference into this prospectus supplement and to be part of this prospectus supplement from the date of filing of such reports and
documents. These documents include periodic reports, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K, as well as proxy statements. We will not, however, incorporate by reference in this prospectus supplement any documents
or portions thereof that are not deemed &ldquo;filed&rdquo; with the SEC, including any information furnished pursuant to Item 2.02 or
Item 7.01 of our Current Reports on Form 8-K after the date of this prospectus supplement unless, and except to the extent, specified
in such Current Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide to each person, including any beneficial owner, to whom a prospectus supplement (or a notice of registration in lieu thereof)
is delivered a copy of any of these filings (other than an exhibit to these filings, unless the exhibit is specifically incorporated
by reference as an exhibit to this prospectus supplement) at no cost, upon a request to us by writing or telephoning us at the following
address and telephone number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">155
Plant Avenue, Hauppauge, NY 11788</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(631)
521-7831</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Secretary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="forword"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement, including the documents incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo;
within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements discuss matters that are not historical
facts. Because they discuss future events or conditions, forward-looking statements may include words such as &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;would,&rdquo;
&ldquo;may,&rdquo; &ldquo;seek,&rdquo; &ldquo;plan,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;forecast,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; negatives thereof
or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions
and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results
of operations or plans expressed or implied by such forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict all the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results
or conditions described in such statements or that our objectives and plans will be achieved, and we do not assume any responsibility
for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places
throughout this prospectus supplement, including the documents incorporated by reference herein, and include information concerning possible
or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies;
future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash
needs, future operations, business plans and future financial results, and any other statements that are not historical facts. All written
and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by
the cautionary statements disclosed under &ldquo;Risk Factors&rdquo; in this prospectus supplement and accompanying prospectus, as such
risk factors may be amended, supplemented or superseded from time to time by reports we file with the SEC, including subsequent Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and in any prospectus supplement or amendments.
Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review
and consider the various disclosures made in this report and in our other filings with the SEC that attempt to advise interested parties
of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events
or circumstances that may arise after the date of this prospectus supplement, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_002"></A>QUESTIONS
AND ANSWERS RELATING TO THIS OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following are examples of what we anticipate will be common questions about this offering. The answers are based on selected information
included elsewhere in this prospectus supplement. The following questions and answers do not contain all of the information that may
be important to you and may not address all of the questions that you may have about this offering. This prospectus supplement, including
the documents we incorporate by reference, contains more detailed descriptions of the terms and conditions of this offering and provides
additional information about our company and our business, including potential risks related to our business, the offering and Common
Stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
is the offering?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We are distributing in the form of a
dividend, at no charge, Unit Subscription Rights entitling holders of our Common Stock and certain Eligible Warrantholders
(pursuant to contractual rights) as of 5:00 p.m., Eastern time, on November 10, 2025, or the Record Date, to purchase
Units at the Unit Subscription Price of $4.00 per Unit. We have granted to you, as a holder of Common Stock, or an Eligible
Warrantholder as of the Record Date, Unit Subscription Rights to purchase two (2) Units for each whole share of Common Stock you beneficially
own on the Record Date. Each Unit will consist of one share of Common Stock, one Series A Right, and one Series B Right. The Unit
Subscription Rights will be transferable until the expiration date of the Unit Subscription Rights Offering, as may be extended
unless earlier terminated. The Series Rights will be transferable from the date of issuance through their respective expiration
dates.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
securities comprise the Units?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit will consist of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            share of Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">one
                                            Series A Right, exercisable commencing on the date of issuance for one share of Common Stock,
                                            and at an exercise price equal to $5.00, and expiring on July 18, 2026; and</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">one
                                            Series B Right, exercisable commencing on the date of issuance for one share
                                            of Common Stock, and at an exercise price equal to $6.00, and expiring on November 20, 2026.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock, Series A Rights and Series B Rights comprising the Units will separate upon the closing of the Subscription
Rights Offering and will be issued separately but may only be purchased as a Unit, and the Units are not transferable and will
not trade as a separate security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>What are the terms of the Series Rights included in the Units?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Series Rights are
exercisable commencing their date of issuance, and the exercise price shall be equal to (i) in the case of the Series A Right, $5.00;
and (ii) in the case of the Series B Right, $6.00. Exercise of the Series Rights requires additional investments
separate from the Unit Subscription Rights Price. The Series Rights will be issued at the closing of the Unit
Subscription Rights Offering. The Series Rights will be transferable until they have expired pursuant to their respective
terms. The Series Rights will be exercisable for cash only in U.S. dollars. The Common Stock issuable upon exercise of the Series
Rights will be issued shortly after the expiration date of the applicable Series Rights subscription period.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><B><I>Will the Unit Subscription Rights and the Series Rights be
listed on a national securities exchange?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">No. The Unit Subscription Rights
and the Series Rights will not be listed on a national securities exchange or quoted on any trading market.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock underlying the Units and included in the Series Rights is expected to be listed on The Nasdaq Stock
Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><B><I>Who are the Eligible Warrantholders who are
being permitted to participate in the Offering?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Certain holders of our outstanding warrants have a contractual right to participate
in this offering, including holders of warrants issued to institutional investors in April 2021, which holders have a right to acquire
1,900,500 shares of common stock as of October 15, 2025, and holders of our public warrants issued in February 2021, which holders have
a right to acquire 1,366,422 shares of our common stock as of October 15, 2025.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
are the basic subscription rights?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
will receive two (2) Unit Subscription Rights for each share of our Common Stock beneficially owned or acquirable upon exercise of their
eligible warrants as of the Record Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If a holder exercises all of its
basic subscription rights in the Unit Subscription Rights Offering, the holder will have the right, which we refer
to as the oversubscription privilege, to purchase additional Units that remain unsubscribed as a result of any unexercised basic subscription
rights. We refer to the basic subscription rights and the oversubscription privilege together as Unit Subscription Rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each basic subscription right held, each rights holder has the opportunity to purchase one Unit at the Unit Subscription Price,
provided that (a) the basic subscription rights may be exercised in aggregate only to purchase whole numbers of Units,
(b) the total Unit Subscription Price payable upon any exercise of Unit Subscription Rights will be rounded to the nearest whole
cent and (c) only whole numbers of shares of Common Stock and Series Rights exercisable for whole numbers of shares will be issued
to a holder in this offering, with any right to fractional shares to which a holder would otherwise be entitled being terminated
without consideration to the holder. We have granted to you, as a holder of Common Stock, or an Eligible Warrantholder, as of
the Record Date, two (2) basic subscription rights for each whole share of Common Stock you beneficially own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For example, assuming availability
of Units, if holder owns 100 shares of Common Stock as of the Record Date, holder will receive 200 basic subscription
rights and will have the right to purchase 200 Units, which Units include 200 shares of Common Stock, Series A Rights
to purchase 200 shares of Common Stock, and Series B Rights to purchase 200 shares of Common Stock. If all of holder&rsquo;s
basic subscription rights and Series Rights are exercised in full, holder will receive a total of 600 shares of Common
Stock in the Rights Offering, subject to potential pro rata adjustment due to the maximum Unit Subscription Rights of Units
limitation of 8,000,000 in the aggregate.  Basic subscription rights will be allocated on a pro rata basis based on the number
of basic subscription rights subscribed by each holder in the event basic subscription rights exercised exceeds 8,000,000 Units. The
maximum number of shares of Common Stock available for issuance in this offering is 24,000,000, consisting of 8,000,000 shares
of Common Stock issuable pursuant to the Unit Subscription Rights as part of the Unit, 8,000,000 shares of Common Stock issuable pursuant
to the Series A Rights and 8,000,000 shares of Common Stock issuable pursuant to the Series B Rights. See &ldquo;May the Unit
Subscription Rights or the Series Rights comprising the Units that I exercise be reduced for any reason?&rdquo;
below for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may exercise all, a portion or none, of your basic subscription rights. If you exercise fewer than all of your basic subscription
rights, however, you will not be entitled to subscribe for any additional Units pursuant to the oversubscription privilege,
described below. See &ldquo;The Rights Offering &mdash; Limitation on the Purchase of Units&rdquo; for a description of certain limitations
on purchase and &ldquo;&mdash; What is the oversubscription privilege?&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
is the oversubscription privilege?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you exercise all of your basic subscription rights in the Unit Subscription Offering, you will have the right, which we
refer to as the oversubscription privilege, to purchase additional Units that remain unsubscribed as a result of any unexercised basic
subscription rights. We refer to the basic subscription right and the oversubscription privilege together as the
Unit Subscription Rights. If you exercise all of your basic subscription rights, you should indicate on your Unit Subscription
Rights certificate, or the form provided by your nominee if your shares are held in the name of a nominee, how many additional Units
you would like to purchase pursuant to your oversubscription privilege, if any. Units shall be allocated pursuant to the oversubscription
privileges pro rata among rights holders who oversubscribe based on the total number of Units oversubscribed by each holder. See
&ldquo;The Rights Offering &mdash; Limitation on the Purchase of Units&rdquo; for a description of certain limitations on purchase and
&ldquo;The Rights Offering &mdash; Over-Subscription Privilege and Allocation of Units Available For Over-Subscription Privileges.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
properly exercise your oversubscription privilege, you must deliver the subscription payment related to your oversubscription
privilege together with your payment for the basic subscription right before the expiration date of the Unit
Subscription Rights Offering. We will not know the total number of unsubscribed Units before the Unit Subscription
Offering expires. If you wish to maximize the number of Units you purchase pursuant to your oversubscription privilege,
you will need to deliver payment in an amount equal to the aggregate Unit Subscription Price for the maximum number of Units
available, assuming that no stockholder other than you has purchased any Units pursuant to such stockholder&rsquo;s basic subscription
right and oversubscription privilege. Any excess subscription payments received by the Subscription Agent will be promptly
returned without interest after the closing of the Unit Subscription Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Oversubscription privilege will only be recognized in the event the subscription
for basic subscription rights is less than 8,000,00 Units, and may be subject to pro rata adjustments. The Subscription Agent will notify
rights holder of the number of Units, if any, allocated to each promptly after the completion of allocation process.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no oversubscription privilege applicable to the Series Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Will there be one closing?&nbsp;</I></B></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We expect to conduct one or more closings in this offering. Units subscribed for pursuant
to the Unit Subscription Rights will be issued in an initial closing promptly following the expiration of the Unit Subscription Rights
offering period. We will have a separate closing for each of the Series Rights after the applicable expiration date of each of the Series
Rights. We reserve the right, in our sole discretion, to determine the timing of each closing, which we anticipate will occur approximately
three business days after the applicable expiration date. The Escrow Agent will hold all funds received from subscribers in escrow until
each applicable closing is completed. Any funds received for unaccepted or unallocated subscriptions will be returned, without interest
or deduction, promptly after the applicable closing.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>May the Unit Subscription Rights or the Series
Rights comprising the Units that I exercise be reduced for any reason?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect every stockholder as of the Record Date or Eligible Warrantholders to subscribe in the Subscription
Rights Offering, and we believe that there will be a sufficient number of Units available to honor your basic subscription
rights in full, subject to potential pro rata adjustment due to the maximum Unit Subscription Rights of Units limitation of 8,000,000
in the aggregate. As a result, if the Unit Subscription Rights Offering is completed, you will receive whole Units to the
full extent you have properly exercised your basic subscription rights in whole or in part for such whole Units, subject
to potential pro rata adjustment due to the maximum Unit Subscription Rights of Units limitation of 8,000,000 in the aggregate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If more than 8,000,000 Unit Subscription
Rights are exercised pursuant to basic subscription rights, we will allocate Units to subscribers on a pro-rata basis based
on the number of basic subscription rights exercised by each subscriber and the total number of basic subscription rights
exercised. In this case, there will be no Units available to satisfy the oversubscription privilege. Separately, sufficient
Units may not be available to honor your request for additional Units pursuant to the oversubscription privilege. If exercises of the
oversubscription privilege exceed the number of Units available, we will allocate the available Units pro-rata among
rights holders who oversubscribed based on the total number of Units for which the holders have oversubscribed pursuant to the oversubsc<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ription
privilege.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the exercise by a holder of the basic subscription right or the oversubscription privilege could, as determined
by us in our sole discretion, potentially result in a limitation on our ability to use net operating losses, tax credits and other tax
attributes, which we refer to as the &ldquo;Tax Attributes,&rdquo; under the Internal Revenue Code of 1986, as amended, and rules promulgated
by the Internal Revenue Service, we may, but are under no obligation to, reduce the exercise by such stockholder of the basic subscription
right or the oversubscription privilege to such number of shares of Common Stock as we, in our sole discretion, shall determine to
be advisable in order to preserve its ability to use the Tax Attributes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Why
are we conducting this offering?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We are conducting this offering as part
of our strategic plan to increase our unrestricted cash balance. We intend to use the net proceeds from this offering, including any
additional net proceeds from the exercise of the Series Rights, for building our inventory, scaling our business in anticipation
of business, increase in marketing, expanding our engineering capabilities and working capital and general corporate purposes.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">After careful review and analysis by
our Board, we believe this offering is in the best interests of our company and its stockholders. However, the board is not making any
recommendation regarding your exercise of the Unit Subscription Rights being distributed to you as a dividend and the Series
Rights comprising the Units.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board considered and evaluated several factors related to this offering, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            current capital resources and our future need for additional liquidity
                                            and capital;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            need for increased financial flexibility in order to enable us to achieve our business plan;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            size and timing of the offering and alternative securities to be offered;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential dilution to our current stockholders if they choose not to participate in
                                            the offering;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            impact on our cumulative net operating losses and their potential limitation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the
                                            transferability of the Unit Subscription Rights and the Series Rights; and</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">alternatives
                                            available for raising capital.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman,serif; margin: 0"><B><I>Am I required to exercise the Unit Subscription
Rights that I receive in this offering or Series Rights comprising the Units?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">No. You may exercise any number of your
Unit Subscription Rights being distributed or Series Rights comprising the Units, or you may choose not to exercise any
of your Unit Subscription Rights being distributed (in which case you will receive no Series Rights). If, however, you
choose not to exercise your Unit Subscription Rights or you exercise less than the full amount of Unit Subscription
Rights or Series Rights available to you and other stockholders fully exercise their Unit Subscription Rights and Series
Rights, the percentage of Common Stock owned by other stockholders will increase relative to your ownership percentage and your voting
and other rights in our Company will likewise be diluted. See &ldquo;Description of Securities&rdquo; in the accompanying prospectus
for a description of the voting and liquidation rights of our Common Stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>May I sell, transfer or assign my Unit Subscription Rights being
distributed</I>?</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Yes. You may transfer, sell or assign
any of the Unit Subscription Rights distributed to you. However, the Unit Subscription Rights are a new issue of securities with no
prior trading market, and we cannot provide you any assurances as to the liquidity of the trading market for the Unit Subscription Rights
or the market value of the Unit Subscription Rights. The Unit Subscription Rights will not be listed on any securities exchange or trading
market. We know of no third party that currently intends to make a market in the Unit Subscription Rights. An active trading market for
the Unit Subscription Rights may not develop or be sustained. If there is no active trading market, or the trading market is not sustained,
you may be unable to sell your Unit Subscription Rights or be unable to sell the Unit Subscription Rights at a price that is satisfactory
to you.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The shares of Common Stock and Series
Rights comprising the Units will be issued separately. Units will not be issued as a separate security and will be non-transferable.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Shares of Common Stock underlying
the Units, including those underlying the Series Rights, are expected to be listed on The Nasdaq Capital Market under the symbol
&ldquo;AMPG.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>May I sell, transfer or assign my Series Rights?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Yes, the Series Rights will be
transferable until they have expired. However, the Series Rights are a new issue of securities with no prior trading market, and
we cannot provide you any assurances as to the liquidity of the trading market for the Series Rights or the market value of the
Series Rights. The Series Rights will not be listed on any securities exchange or trading market. We know of no third party
that currently intends to make a market in the Series Rights. An active trading market for the Series Rights may not develop
or be sustained. If there is no active trading market, or the trading market is not sustained, you may be unable to sell your Series
Rights or be unable to sell the Series Rights at a price that is satisfactory to you.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>How do I exercise my Unit Subscription Rights
or Series Rights if my shares of Common Stock or eligible warrants are held in my name?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares of Common Stock or eligible warrants in your name and you wish to participate in the offering, you must
deliver (i) a properly completed and duly executed Unit Subscription Rights certificate and Series Rights certificate
and all other required subscription documents to the Subscription Agent, and (ii) the payment of the maximum price for the Unit
Subscription Rights and exercise price for the respective Series Rights, if applicable, to the Escrow Agent for the
offering before 5:00 p.m., Eastern time, on the applicable expiration date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
follow the delivery instructions on the Unit Subscription Rights Certificate and Series Rights Certificate. Do not deliver documents
to the Company or payment to the Subscription Agent. You are solely responsible for completing delivery of your Unit
Subscription Rights certificate and Series Rights Certificate, all other required subscription documents to the Subscription Agent
and subscription payment to the Escrow Agent. You should allow sufficient time for delivery of your subscription materials to
the Subscription Agent and payment to the Escrow Agent so that they may be received by them by 5:00 p.m., Eastern time,
on the applicable expiration date. See &ldquo;To whom should I send my forms and payment to exercise my Unit Subscription Rights and
Series Rights?&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you send a payment that is insufficient to purchase the number of Units you
requested or insufficient to exercise the number of rights you requested pursuant to your Series Rights, or if the number of Units you
requested or number of rights you requested is not specified in the forms, the payment received will be applied to exercise your Unit
Subscription Rights and Series Rights to the fullest extent possible based on the amount of the payment received pursuant to your Unit
Subscription Rights and Series Rights. Any payment that is received but not so applied will be refunded to you without interest or penalty
(subject to the rounding of the amount so applied to the nearest whole cent).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>What form of payment is required to exercise my Unit Subscription Rights
to purchase Units and the Series Rights?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">As described in the instructions accompanying
the Unit Subscription Rights certificate and Series Rights Certificate, payments must be submitted and delivered to and received by the Escrow Agent
by the applicable expiration date, and payment must be made in U.S. dollars. Payments may be only made by wire transfer to the Escrow
Agent pursuant to the instructions that will accompany your Unit Subscription Rights certificate and/or Series Rights Certificates. Checks, certified
checks or cashier&rsquo;s checks will <U>not</U> be accepted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares of Common Stock in the name of a broker, dealer, custodian bank or other nominee (including any mobile investment
platform), separate payment instructions may apply. Please contact your nominee, if applicable, for further payment instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
do I exercise my Unit Subscription Rights being distributed and Series Rights comprising the Units if my shares of Common
Stock are held in the name of a broker, dealer, custodian bank or other nominee?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If you hold shares of Common Stock in
the name of a broker, dealer, custodian bank or other nominee (including any mobile investment platform) that uses the services of Depository
Trust Company, then Depository Trust Company will credit two basic subscription rights to your nominee record holder for each
share of Common Stock that you beneficially owned as of the Record Date. If you are not contacted by your nominee (including any mobile
investment platform), you should contact your nominee as soon as possible. We expect such nominee may exercise the Unit Subscription
Rights and the Series Rights on your behalf of the exercising beneficial owner through DTC by: (1) providing a certification
as to the aggregate number of Unit Subscription Rights or Series Rights exercised by the beneficial owner on whose behalf
such nominee is acting, and (2) instructing DTC to charge the nominee&rsquo;s applicable DTC account for the Unit Subscription Price
in the case of the Unit Subscription Rights, and the exercise price in the case of the Series Rights to facilitate the
delivery of the full payment to the Escrow Agent with respect to the payment for the Unit Subscription Rights or the Series Rights.
DTC must receive the subscription instructions and payment for the Unit Subscription Rights and/or the Series Rights exercised
prior to the applicable expiration date.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>How soon must I act to exercise my Unit Subscription
Rights being distributed or Series Rights comprising the Units?</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If you elect to exercise any of
your Unit Subscription Rights or Series Rights, (i) the Subscription Agent must receive your properly completed and duly executed Unit Subscription Rights certificate or Series Rights certificates, along with all other required subscription documents, and (ii)
the Escrow Agent must receive your full subscription payment, before 5:00 p.m., Eastern time, on the applicable expiration date.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If you hold shares in the name of a broker,
dealer, custodian bank or other nominee (including any mobile investment platform), your nominee may establish an earlier deadline before
the expiration of this offering by which time you must provide the nominee with your instructions and payment to exercise your Unit
Subscription Rights being distributed or Series Rights comprising the Units.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Although we will make reasonable attempts
to provide this prospectus supplement to our stockholders to whom rights are distributed, this offering and all related Unit Subscription
Rights being distributed and Series Rights comprising the Units will expire at 5:00 p.m., Eastern time, on the applicable
expiration date, whether or not we have been able to locate and deliver this prospectus supplement to you or any other stockholder.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>After
I exercise my Unit Subscription Rights being distributed and Series Rights comprising the Units, can I change my mind?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
Once made, all exercises of the Unit Subscription Rights being distributed and Series Rights comprising the Units are irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Can
this offering be terminated or extended</I>?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Yes. If we terminate this offering, neither
we nor the Subscription Agent, and the Escrow Agent will have any obligation with respect to Unit Subscription Rights being distributed
or Series Rights comprising the Units that have been exercised except to promptly return, without interest or penalty, any subscription
payment received from you and we would not be obligated to issue Units to rights holders who have exercised their Unit Subscription
Rights being distributed or shares of Common Stock to rights holder who have exercised their Series Rights comprising the
Units prior to termination.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may extend this offering for one or more additional periods in our sole discretion not to exceed 30 days in the aggregate from the initial
expiration date, in which case all basic subscription rights and oversubscription privileges exercised during the extension period
will be filled subject to aggregate unit issuance limitations and pro rata adjustments. We will announce any extension in a press
release issued no later than 9:00 a.m., Eastern time, on the business day after the most recently announced expiration date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>What happens if there is an undersubscription
on the expiration date?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have currently not entered into any standby
purchase agreement, backstop commitment or similar arrangement in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
were the Unit Subscription Price and exercise price of the Series Rights comprising the Units determined?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Unit Subscription Price and exercise price of Series Rights were set by our Board, considering, among other things, input from
the dealer-manager for this offering. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board considered, among other things, the following factors in determining the price for purposes of establishing the Unit Subscription
Price and exercise price:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            current and historical trading prices of our Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            price at which holders might be willing to participate in this offering;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            need for additional capital and liquidity;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost of capital from other sources; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">comparable
                                            precedent transactions, including the percentage of shares offered, the terms of the Unit
                                            Subscription Rights being distributed and Series Rights comprising the Units,
                                            the Unit Subscription Price and exercise prices immediately prevailing closing price of those
                                            offerings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the review of these factors and following discussion with the dealer-manager, our Board also reviewed our history and
prospects, including our prospects for the future, our past and present burn rate and cash requirements, the outlook for our industry,
and our current financial condition. Our Board believes that the pricing of the Unit Subscription Price provides an incentive to our
current stockholders to participate in this offering and exercise their rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Unit Subscription Price or exercise price of Series Rights comprising the Units does not necessarily bear any relationship to
any established criteria for value, other than the current market price of our Common Stock on certain dates. You should not consider
the Unit Subscription Price or exercise price of Series Rights comprising the Units as an indication of the actual value of our
Company. We cannot assure you that the market price of our Common Stock will not decline during or after this offering. You should obtain
a current price quote for our Common Stock before exercising your rights and make your own assessment of our business and financial condition,
our prospects for the future, and the terms of this offering. Once made, all exercises of the Unit Subscription Rights being distributed
and Series Rights comprising the Units are irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Has
the Board made a recommendation to stockholders regarding the exercise of Unit Subscription Rights under this offering or Series
Rights comprising the Units?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
Our Board has not made, nor will it make, any recommendation to stockholders regarding the exercise of Unit Subscription Rights
being distributed or the Series Rights comprising the Units in this offering. We cannot predict the price at which shares of our
outstanding Common Stock will trade after this offering. You should make an independent investment decision about whether or not to exercise
your Unit Subscription Rights being distributed or Series Rights comprising the Units. Rights holders who exercise Unit
Subscription Rights being distributed or Series Rights comprising the Units risk investment loss on new money invested. We
cannot assure you that the market price for Common Stock will remain above the price payable per share of Common Stock or the exercise
price, or that anyone purchasing Units or exercising Series Rights to purchase shares of Common Stock at the exercise price will
be able to sell those shares in the future at the same price or a higher price. If you do not exercise your Unit Subscription Rights
being distributed or Series Rights comprising the Units, you will lose any value represented by your Unit Subscription Rights
being distributed or Series Rights comprising the Units, and if you do not exercise your rights in full, your percentage ownership
interest and related rights in our company will be diluted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
when must I purchase shares of Common Stock in order to participate in this offering? May I participate in this offering if I sell my
Common Stock after the record date?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for this offering is 5:00 p.m., Eastern time, on November 10, 2025. If you purchase shares of our
Common Stock and do not settle such purchase by 5:00 p.m., Eastern time, on November 7, 2025 you will not receive Unit Subscription
Rights with respect to such shares. If you own Common Stock as of the Record Date, you will receive two (2) Unit
Subscription Rights for each share of Common Stock beneficially owned and may participate in this offering even if you subsequently
sell your Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Are
there any risks associated with this offering</I></B><I>?</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
The exercise of your Unit Subscription Rights being distributed and Series Rights comprising the Units involves risks.
Exercising your Unit Subscription Rights being distributed and Series Rights comprising the Units involves the purchase
of Common Stock and should be considered as carefully as you would consider any other equity investment. Among other things, you should
carefully consider the risks described under the heading &ldquo;Risk Factors&rdquo; in this prospectus supplement and the accompanying
prospectus and all other information contained in this prospectus supplement and the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Will
the directors and executive officers participate in this offering?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent they hold Common Stock or are Eligible Warrantholders as of the Record Date, our directors and executive officers are
entitled to participate in this offering on the same terms and conditions applicable to all other stockholders. None of our directors
or executive officers have entered into any binding commitment or agreement to exercise Unit Subscription Rights received in the
offering, but some may participate in the offering at varying levels, though there can be no assurances any of our principal stockholders,
directors and executive officers will participate in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>When
will I receive my shares of Common Stock and Series Rights?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect holders whose shares are held of record by Cede &amp; Co., the nominee of Depository Trust Company, or by any other depository
or nominee on their or their broker-dealers&rsquo; behalf will have any shares of Common Stock and the Series Rights comprising
the Units they acquire credited to the account of Cede &amp; Co. or such other depository or nominee. With respect to all other
stockholders or Eligible Warrantholders, the shares of Common Stock and all Series Rights will be issued in book-entry,
or uncertificated form meaning you will receive a direct registration account book-entry statement from our Subscription Agent
reflecting the ownership of these securities if you are a holder of record of shares, which may take up to 15 business days from the
applicable expiration date. It is anticipated that there will be a separate closing for the Unit Subscription Rights, Series A Right
and the Series B Right shortly after the applicable expiration date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
effects will this offering have on our outstanding Common Stock</I>?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2025, we had 20,638,095 shares of common stock issued and outstanding.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Based on the number of shares of Common Stock outstanding as of October 15, 2025, assuming the sale of all offered Units and no exercise
of the Series Rights included in the Units, we will have up to approximately 28,638,095 shares of Common Stock outstanding,
representing an increase of approximately 39% of our outstanding shares. If you fully exercise your basic subscription rights,
your proportional Common Stock interest in our company will not decrease. If all of the Series Rights to purchase shares
of our Common Stock are exercised in full at the Unit Subscription Price (assuming that stockholders exercise Unit Subscription Rights
for all of the Units that we are offering), we will have up to approximately 44,638,095 shares of Common Stock outstanding, representing
an increase of approximately 116% in our outstanding shares based on the number of shares of Common Stock outstanding as of October
15, 2025. If you exercise only a portion, or none, of your basic subscription rights, your interest in our company will be diluted
and your proportional interest in our company will decrease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of Common Stock outstanding listed above assumes that (a) all of the other shares of Common Stock outstanding as of
October 15, 2025 will remain issued and outstanding and owned by the same persons as of the Record Date and as of the closing of this
offering, and (b) we will not issue any shares of Common Stock in the period between October 15, 2025 and the closing date of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
much will we receive from this offering, and how will the proceeds be used?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
all offered Units are sold and assuming no exercise of the Series Rights, and based on the 8,000,000 maximum number of
Units available for issuance in this offering, we estimate our net proceeds from the offering will total approximately $29,383,500,
after deducting fees and expenses of Moody Capital, as dealer-manager, and our other estimated offering expenses. We intend to use the
net proceeds from this offering, including any additional net proceeds from the exercise of the Series Rights, for working capital
general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
my exercise of Unit Subscription Rights is not valid or if this offering is not completed, will my subscription payment be refunded
to me?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Yes. the Escrow Agent will
hold all funds it receives in escrow until the applicable closing or the completion or termination of the offering. If
your exercise of Unit Subscription Rights being distributed is deemed not to be valid or this offering is not completed,
all subscription payments received by the Escrow Agent will be promptly returned, without interest or penalty, following the expiration
of the offering. If you own shares through a nominee (including any mobile investment platform), it may take longer for you to receive
your Subscription Price or exercise price repayment because the Escrow Agent will return payments through your nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
fees or charges apply if I purchase Units in this offering?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not charging any fee or sales commission to issue the Unit Subscription Rights to you or, if you exercise any of your Unit
Subscription Rights, to issue Units to you. If you exercise your Unit Subscription Rights through a broker, dealer, custodian
bank or other nominee (including any mobile investment platform), you are responsible for paying any fees your nominee may charge you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
are the U.S. federal income tax consequences of exercising my Unit Subscription Rights being distributed or Series Rights
comprising the Units?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, a rights holder should generally not recognize income or loss in connection with the receipt or exercise
of the Unit Subscription Rights in this offering or Series Rights comprising the Units. You should consult your tax advisor
as to your particular tax consequences resulting from the offering. For a summary of certain U.S. federal income tax consequences of
this offering, see &ldquo;Material U.S. Federal Income Tax Considerations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>To
whom should I send my forms and payment to exercise my Unit Subscription Rights and Series Rights?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>Broker, dealer, custodian
bank or other nominee</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares of Common Stock are held in the name of a broker, dealer, custodian bank or other nominee (including any mobile investment
platform), then you should deliver all required subscription documents and subscription payments pursuant to the instructions provided
by your nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>Common Stock and Eligible
Warrantholders Held In Name</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares of Common Stock or eligible warrants are held in your name, then you should send your Unit Subscription Rights
certificate and/or Series Rights certificate, and all other required subscription documents to the Subscription
Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>If
                                            delivering by hand</U>:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
    Transfer, LLC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
    Lafayette Place</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
    NY 11598</FONT></P></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>If
                                            delivering by mail or overnight courier</U>:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
    Transfer, LLC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
    Lafayette Place</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
    NY 11598</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Subscription Agent can be reached by telephone
at (212) 828-8436, or by email at action@vstocktransfer.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
and, if applicable, your nominee are solely responsible for completing delivery to the Subscription Agent your Unit
Subscription Rights certificate and/or Series Rights Certificate, as well as for completing delivery of all other required
subscription documents. You should allow sufficient time for delivery of your subscription materials to the Subscription
Agent. If you hold your Common Stock through a broker, dealer, custodian bank or other nominee (including any mobile investment
platform), your nominee may establish an earlier deadline before the applicable expiration date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>Payment Made by Common
Stockholder and Eligible Warrantholders Held In Name</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">You and, if applicable,
your nominee are solely responsible for delivering your subscription payment by wire transfer to the Escrow Agent pursuant to the instructions you will receive with the subscription documents. You should allow
sufficient time for delivery of your payment and clearance of payments before applicable expiration date. If you hold your Common
Stock through a broker, dealer, custodian bank or other nominee (including any mobile investment platform), your nominee may
establish an earlier deadline before the applicable expiration date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Who
is the dealer-manager?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moody
Capital will act as dealer-manager for this offering. Under the terms and subject to the conditions contained in the dealer-manager agreement,
Moody Capital will use its commercially reasonable efforts to solicit the exercise of the Unit Subscription Rights being distributed
and Series Rights comprising the Units. We have agreed to pay Moody Capital certain fees for acting as dealer-manager and to reimburse
it for certain expenses incurred in connection with this offering. Moody Capital is not underwriting this offering. Moody Capital is
not making any recommendation with respect to such Unit Subscription Rights (including with respect to the exercise or expiration
of such Unit Subscription Rights), shares of Common Stock or Series Rights comprising the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Who
should I contact if I have other questions</I>?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions regarding this offering, completion of the Unit Subscription Rights certificate, Series Rights Certificate or any other
subscription documents or submitting payment in the offering, please contact MacKenzie Partners Inc., the information agent, by
telephone at (212) 929-5500 (bankers and brokers) or (800) 322-2885 (all others) or by email at AMPG@mackenziepartners.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_003"></A>SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights certain information about us, this offering, and selected information contained elsewhere in or incorporated by reference
into this prospectus supplement. This summary is not complete and does not contain all of the information that you should consider before
deciding whether to invest in our Units, Common Stock and Series Rights. For a more complete understanding of our company and
this offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying
prospectus, including the information incorporated by reference in this prospectus supplement, and the information included in any free
writing prospectus that we have authorized for use in connection with this offering, including the information under the heading &ldquo;Risk
Factors&rdquo; beginning on page S-21 and in the documents incorporated by reference into this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Overview</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group, Inc. (&ldquo;AMPG,&rdquo; &ldquo;AmpliTech&rdquo; or the &ldquo;Company&rdquo;), incorporated in 2010 in the state of Nevada,
is the parent company of AmpliTech, Inc., and the Company&rsquo;s divisions, Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech
Group MMIC Design Center (&ldquo;AGMDC&rdquo;) and AmpliTech Group True G Speed Services (&ldquo;AGTGSS&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech,
Inc. designs, engineers and assembles micro-wave component-based amplifiers that meet individual customer specifications. Our products
consist of Radio Frequency (&ldquo;RF&rdquo;) amplifiers and related subsystems, operating at multiple frequencies from 50kHz to 44GHz,
including low noise amplifiers (&ldquo;LNA&rdquo;), medium power amplifiers, cryogenic amplifiers, and custom assembly designs for the
global satellite communications, telecom (5G &amp; IoT), space, defense, and quantum computing markets. We also offer non-recurring engineering
services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time plus material basis. We have both
domestic and international customers in such industries as aerospace, governmental, defense and commercial satellite.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specialty
Microwave designs and manufactures state-of- the-art precision SATCOM microwave components, RF subsystems and specialized electronic
assemblies for the military and commercial markets, flexible and rugged waveguides, wave guide adapters and more.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2021, we acquired substantially all of the assets of Spectrum Semiconductor Materials Inc. (&ldquo;SSM&rdquo;), a globally
authorized distributor of integrated circuit (IC) packaging and lids for semiconductor device assembly, prototyping, testing, and production
requirements founded in 1990 and headquartered in San Jose, CA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, the Company opened AGMDC, a monolithic microwave integrated circuits (&ldquo;MMIC&rdquo;) chip design center, in Texas and has
started to implement several of its proprietary amplifier designs into MMIC components. MMICs are semiconductor chips used in high-frequency
communications applications. MMICs are widely desired for power amplification solutions to service emerging technologies, such as phased
array antennas and quantum computing. MMICs carry a smaller footprint enabling them to be incorporated into a broader array of systems
while reducing costs. AGMDC designs, develops and manufactures state-of-the-art signal processing components for satellite and 5G communications
networks, defense, space and other commercial applications, allowing the Company to market its products to wider base of customers requiring
high technology in smaller packages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, we formed our AGTGSS division to enable &ldquo;true G speeds&rdquo; to the industry. AGTGSS&rsquo; main function will be
to plan and configure 5G radio systems and make them O-RAN compliant. AGTGSS will implement AmpliTech&rsquo;s low noise amplifier devices
in these systems to promote greater coverage, longer range and faster speeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, we entered into an asset purchase agreement, Titan Crest, LLC, a Delaware limited liability company (&ldquo;Titan&rdquo;),
and its affiliate, to purchase certain assets including intellectual property used in developing, manufacturing, marketing and selling
products that use radio frequency technology (&ldquo;5G ORAN radio products&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to patent our proprietary IP and trade secrets that were used in small volume niche markets and expand our capabilities through
strategic partnerships, joint ventures, mergers/acquisitions with key industry leaders in the 5G/6G, quantum computing, and cybersecurity
markets. We believe this will enable us to scale up our products and revenue by developing full systems and subsystems with our unique
technology as a core component, which we expect will position us as a global leader in these rapidly emerging technology sectors and
addresses large volume markets as well, such as cellphone handsets, laptops, server networks, and many other applications that improve
everyday quality of life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s research and development initiative to expand its product line of low noise amplifiers to include its new 5G and wireless
infrastructure products, cryogenic amplifiers and MMIC designs is progressing significantly. Our combined engineering and manufacturing
resources are expected to complement the development of new subsystems for satellite, wireless, and 5G infrastructures, as well as advanced
military and commercial markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Corporate History and Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group, Inc. was incorporated under the laws of the State of Nevada on December 30, 2010. On August 13, 2012, the Company acquired
AmpliTech Inc., by issuing 833,750 shares of the Company&rsquo;s Common Stock to the stockholders of AmpliTech Inc. in exchange
for 100% of the outstanding shares of AmpliTech Inc. (the &ldquo;Share Exchange&rdquo;). After the Share Exchange, the selling stockholders
owned 60,000 shares of the outstanding 893,750 shares of Company Common Stock, resulting in a change in control. Accordingly, the transaction
was accounted for as a reverse acquisition in which AmpliTech, Inc. was deemed to be the accounting acquirer, and the operations of the
Company were consolidated for accounting purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
designs, engineers and assembles microwave component based low noise amplifiers (&ldquo;LNA&rdquo;) that meet individual customer specifications.
Application of the Company&rsquo;s proprietary technology results in maximum frequency gain with minimal background noise distortion
as required by each customer. The Company has both domestic and international customers in such industries as aerospace, governmental,
defense and commercial satellite.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 12, 2019, AmpliTech Group, Inc. acquired substantially all of the assets of Specialty Microwave Corporation, a privately
held company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and goodwill. Following
the closing of the asset purchase, we hired all eight team members of SMW. In connection with the acquisition, the Company began using
the trade name &ldquo;Specialty Microwave&rdquo;. Specialty designs and manufactures passive microwave components and related subsystems
that meet individual customer specifications for both domestic and international customers for use in satellite communication ground
networks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2021, AmpliTech Group, Inc.&rsquo;s Common Stock and warrants commenced trading on NASDAQ under the symbols &ldquo;AMPG&rdquo;
and &ldquo;AMPGW,&rdquo; respectively. A reverse split of the outstanding Common Stock at a 1-for-20 ratio became effective February
17, 2021, as of 12:01 a.m., Eastern Time. All share amounts have been retroactively re-stated to reflect the reverse split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2021, AmpliTech Group, Inc. entered into an Asset Purchase Agreement with SSM, pursuant to which AmpliTech would acquire
substantially all of the assets of SSM. SSM, located in Silicon Valley (San Jose, CA), was a global authorized distributor of IC packaging
and lids for semiconductor device assembly, prototyping, testing, and production requirements. The acquisition was completed on December
15, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, the Company opened a MMIC chip design center in Texas and has started to implement several of its proprietary amplifier designs
into MMIC components. MMICs are semiconductor chips used in high-frequency communications applications. MMICs are widely desired for
power amplification solutions to service emerging technologies, such as phased array antennas and quantum computing. MMICs carry a smaller
footprint enabling them to be incorporated into a broader array of systems while reducing costs. AGMDC designs, develops and manufactures
state-of-the-art signal processing components for satellite and 5G communications networks, defense, space and other commercial applications,
allowing the Company to market its products to a wider base of customers requiring high technology in smaller packages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, our AGTGSS division was founded to serve and provide complete system integration and ORAN compliant O-RU&rsquo;s (Radio
Units) for telcos, enabling the industry to access &lsquo;True 5G Speeds&rsquo;. AGTGSS provides Managed Services, Cyber Security, Cloud
Services, Data Sciences and Telco Cloud Services. AGTGSS will also be providing full installation of Private 5G Networks (P5G) which
includes the deployment of AmpliTech Group developed radio units. AGTGSS will implement AmpliTech&rsquo;s low noise amplifier devices
in these systems to promote greater coverage, longer range and faster speeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, we entered into an asset purchase agreement, as amended by that certain amendment dated April 15, 2025, with Titan, and
its affiliate (as amended, the &ldquo;Titan APA&rdquo;) to purchase certain assets including intellectual property used in developing,
manufacturing, marketing and selling products that use radio frequency technology (&ldquo;5G ORAN radio products&rdquo;). The
aggregate purchase price for the assets is $8,000,000, which consists of $4,000,000 in cash and $4,000,000 in restricted shares of Common
Stock of which the first $3,500,000 in cash was paid and $1,500,000 in restricted Common Stock was issued on April 24, 2025. The remaining
$500,000 in cash to be paid and $2,500,000 in shares of restricted Common Stock will be issued to Titan upon the transfer of the 5G ORAN
radio products&rsquo; technology and intellectual property rights by Titan to the Company. The second milestone is expected to be achieved
towards the end of the year 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive offices are located at 155 Plant Avenue, Hauppauge, NY 11788, and our telephone number is (631) 521-7831. Our website address
is <U>http://www.amplitechgroup.com</U>. We have included our website address as an inactive textual reference only. We are not including
the information contained at <U>http://www.www.amplitechgroup.com</U>., or at any other website address, as part of, or incorporating
it by reference into, this prospectus or any accompanying prospectus supplement or related free writing prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_004"></A>THE
RIGHTS OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman,serif; margin: 0"><I>Before deciding whether to exercise your Unit Subscription
Rights and Series Rights, you should carefully read this prospectus supplement, including the information set forth under the heading
&ldquo;Risk Factors&rdquo; and the information incorporated by reference into this prospectus supplement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Terms
of Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are distributing in the form of a dividend, at no charge, Unit Subscription Rights entitling holders of our Common Stock and Eligible
Warrantholders as of the record date of 5:00 p.m., Eastern time, on November 10, 2025, to purchase Units at the
Unit Subscription Price of $4.00 per Unit. Each Unit will consist of one share of Common Stock, one Series A Right,
and one Series B Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">Common Stockholders and
Eligible Warrantholders will receive two (2) Unit Subscription Rights for each share of our Common Stock beneficially owned
as of the Record Date. Your Unit Subscription Rights will consist of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                            basic subscription right, which will entitle you to purchase one Unit for each Unit
                                            Subscription Right; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                            oversubscription privilege, which will be exercisable only if you exercise your basic
                                            subscription right in full and will entitle you to purchase additional Units for which
                                            other rights holders do not subscribe, subject to pro rata allocation of those additional
                                            Units to participating rights holders in proportion to the number of oversubscription Units
                                            for which they subscribed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit will consist of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            share of Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">one
                                            Series A Right, exercisable commencing on the date of issuance for one share of Common Stock,
                                            and at an exercise price that is equal to $5.00 and expiring on July 18, 2026;
                                            and</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">one
                                            Series B Right, exercisable commencing on the date of issuance for one share of Common Stock,
                                            and at an exercise price that is equal to $6.00, and expiring on November 20, 2026.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our Common Stock and the Series Rights may only be purchased as a Unit but will be issued separately. The Unit Subscription
Rights being distributed and the Series Rights comprising the Units will be exercisable commencing on the date of issuance
and are exercisable for cash only in U.S. dollars.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of determining the
number of Units a holder may acquire in this offering, broker-dealers, trust companies, banks or others whose shares are held by
record by Cede &amp; Co. or by any other depository or nominee will be deemed to be holders of the Unit Subscription Rights that are
issued to Cede &amp; Co., or the other depository or nominee on their behalf.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; text-indent: 0.5in; margin: 0">There is no minimum number of Unit Subscription Rights
or Series Rights that must be exercised in order to close.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B>Subscription Agent and Escrow Agent</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We have engaged VStock Transfer, LLC
to serve as the Subscription Agent for the Unit Subscription Rights and the Series Rights. We have engaged Citizens Bank, N.A., a national
banking association acting through its Institutional Services Group located at 1 Citizens Drive, Riverside, RI 02915 to serve as escrow
agent (the &ldquo;Escrow Agent&rdquo;) to hold in escrow the funds we receive from subscribers for the Unit Subscription Rights and the
Series Rights until the applicable closing or cancellation or termination of the offering. If you want to exercise the Unit Subscription
Rights and you are the record holder of your shares or Eligible Warrantholders on the Record Date, you must submit (i) your properly
completed and executed subscription documents to our Subscription Agent; and (ii) payment to the Escrow Agent before the applicable expiration
date. If you hold your shares or Series Rights through your broker, dealer, bank or other nominee, you should promptly contact your broker,
dealer, bank or other nominee and submit your subscription documents and payment in accordance with the instructions and within the time
period provided by your broker, dealer, bank or other nominee.</P>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Over-Subscription Privilege and Allocation
of Units Available For Over-Subscription Privileges</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you exercise your basic
subscription rights in full, you may also choose to exercise your over-subscription privilege. Subject to the ownership limitation described
below, we will seek to honor the over-subscription requests in full. If over-subscription requests exceed the number of units available,
however, we will allocate the available units pro rata among the holders in proportion to the number of over-subscription units for which
they have subscribed. The Subscription Agent will determine the over-subscription allocation based on the formula described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">To the extent your aggregate
subscription payment for the actual number of unsubscribed units available to you pursuant to the over-subscription privilege is less
than the amount you actually paid in connection with the exercise of the over-subscription privilege, you will be allocated only the
number of unsubscribed units available to you, and any excess subscription payment will be promptly returned to you, without interest
or penalty, after the expiration of this offering. See &ldquo;The Rights Offering &mdash; Limitation on the Purchase of Units&rdquo;
for a description of certain limitations on purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We can provide no assurances
that you will actually be entitled to purchase the number of units issuable upon the exercise of your over-subscription privilege in
full at the expiration of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">There is no over-subscription
privilege applicable to the Series Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Limitation on the Purchase of Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you own a small number
of shares of common stock, your exercise of your Unit Subscription Rights may not result in the issuance of any Units. Although we intend
to honor all properly exercised Unit Subscription Rights, there are circumstances under which a stockholder may not receive any shares
upon exercising such rights. If the total number of Units requested in connection with the exercise of basic Unit Subscription Rights
exceeds the maximum number of Units that may be issued under this Prospectus Supplement or the Registration Statement, allocations may
be reduced on a pro rata basis, which could result in certain stockholders receiving none of the shares requested. In any such case,
any payments made in connection with your subscription will be returned without interest, and you may not receive any Units even though
you exercised your rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In the event that the exercise by a stockholder of the basic Unit Subscription
Right or the oversubscription privilege could, as determined by us in our sole discretion, potentially result in a limitation on our ability
to use net operating losses, tax credits and other tax attributes, which we refer to as the &ldquo;Tax Attributes,&rdquo; under the Internal
Revenue Code of 1986, as amended, which we refer to as the &ldquo;Code,&rdquo; and rules promulgated by the Internal Revenue Service,
we may, but are under no obligation to, reduce the exercise by such stockholder of the basic Unit Subscription Right or the over-subscription
privilege to such number of units as we in our sole discretion shall determine to be advisable in order to preserve our ability to use
the Tax Attributes. If the amount of Unit Subscription Rights that you exercise is so limited, any amount not used for purchases will
be promptly refunded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B>Expiration Dates</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Unit Subscription Rights, consisting of basic subscription rights and oversubscription privileges, may be exercised at
any time during the subscription period, which commences on November 11, 2025 and expires at 5:00 p.m., Eastern time, on December
10, 2025, unless we extend or terminate this offering. Once made, all exercises of Unit Subscription Rights are irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may extend the offering for the Unit Subscription Rights for one or more additional periods in our sole discretion not to exceed
30 days in the aggregate from the expiration date. We will announce any extension in a press release issued no later than 9:00
a.m., Eastern time, on the business day after the most recently announced expiration date. If we extend the offering, all basic subscription
rights and oversubscription privileges exercised during the extension period will be filled subject to aggregate unit issuance
limitations and pro rata adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Unit Subscription Rights
may only be exercised in aggregate for whole numbers of Units. Only whole numbers of shares of Common Stock and Series Rights
exercisable for whole numbers of shares will be issuable to you in this offering; any right to a fractional share to which you would
otherwise be entitled will be terminated, without consideration to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Series A Rights and Series
B Rights may be exercised commencing on their date of issuance and continuing until their expiration dates, respectively, July 18, 2026 and November 20, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transferability</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Unit Subscription Rights</I>. The
Unit Subscription Rights are evidenced by a Unit Subscription Rights certificate and are transferable. There is no trading market available for the
Unit Subscription Rights on any securities exchange or nationally recognized trading system, and we do not expect a trading market to
develop. We do not intend to list the Unit Subscription Rights on any securities exchange or nationally recognized trading market. Without
a trading market, the liquidity of the Unit Subscription Rights will be extremely limited. The Common Stock issuable upon exercise of
the Unit Subscription Rights are currently traded on The Nasdaq Capital Market. The Unit Subscription Rights will not be listed on any
securities exchange or trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Units</I>.
Shares of our Common Stock and the Series Rights may only be purchased as a Unit but will be issued separately. Units will not
be issued as a separate security and will be non-transferable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common
Stock</I>. Shares of Common Stock included in Units will be separately transferable following their issuance. All of the shares of Common
Stock issued in this offering upon exercise of the Unit Subscription Rights being distributed and the Series Rights comprising
the Units are expected to be listed on The Nasdaq Capital Market under the symbol &ldquo;AMPG.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Series Rights</I>. The Series
Rights included in the Units will be evidenced by a certificate and will be separately transferable following their issuance.
The Series Rights will not be listed for trading on any other securities exchange or trading market.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
the sale of all offered Units and no exercise of the Series Rights, and based on the 8,000,000 maximum number of Units available
for issuance in this offering, we estimate our net proceeds from this offering will total approximately $29,383,500, after deducting
fees and expenses of Moody Capital, as dealer-manager, and our other estimated offering expenses. We intend to use the net proceeds from
this offering, including any additional net proceeds from the exercise of the Series Rights, for scaling domestic manufacturing and
operations; advancing R&amp;D and product commercialization; deepening vertical integration and supply-chain resilience; engaging in
strategic partnerships; supporting corporate growth initiatives, and working capital and general corporate purposes. See &ldquo;Use
of Proceeds&rdquo; for a more detailed description of the intended uses of the net proceeds from this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscription
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to obtain subscription information, you should contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MacKenzie</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            Partners Inc., which will act as the information agent in connection with this offering,
                                            by telephone at (212) 929-5500 (bankers and brokers) or (800) 322-2885 (all others) or
                                            by email at AMPG@mackenziepartners.com.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                            broker-dealer, trust company or other nominee (including any mobile investment platform)
                                            where your Unit Subscription Rights are held.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscription
Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to exercise your Unit Subscription Rights being distributed, including your oversubscription privilege, and your Series
Rights comprising the Units, you should deliver a properly completed and duly executed Unit Subscription Rights certificate
and/or Series Rights certificate, along with the other required documents to VStock Transfer, LLC, the Subscription Agent
for this offering by the applicable expiration date. Documents should be mailed to VStock Transfer, LLC, 18 Lafayette Place, Woodmere,
NY 11598, Subscription Agent, who can be reached by telephone at (212) 828-8436, or by email at <U>action@vstocktransfer.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">You must deliver your payment for
your subscription to the Escrow Agent by wire pursuant to the instructions that will accompany the Unit Subscription Rights certificate and/or the
Series Rights certificates. <B>Personal checks, cashier&rsquo;s check or certified checks will <U>not</U> be accepted. Do not send your
payment to the Subscription Agent or the Company. DO NOT SEND ANY DOCUMENTS TO THE COMPANY.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Dates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are important dates for this offering:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dates</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
  date </FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
  10, 2025</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencement
  of Unit Subscription Period</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
11, 2025</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B>UNIT SUBSCRIPTION RIGHTS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deadline
for delivery of Unit Subscription Rights certificates and required documents and payment of Unit Subscription Price &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
December 10, 2025</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration
  date for Unit Subscription Rights</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
  10, 2025</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extension
  period (if any)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to January 9, 2026</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SERIES RIGHTS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%; font: 10pt Times New Roman,serif"><FONT STYLE="font-size: 10pt">Deadline for delivery of Series A Rights
    certificates and required documents <BR>
and payment of exercise price</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman,serif"><FONT STYLE="font-size: 10pt">July 18, 2026</FONT><FONT STYLE="font-size: 10pt">
    </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman,serif"><FONT STYLE="font-size: 10pt">Expiration date for Series A Rights </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman,serif"><FONT STYLE="font-size: 10pt">July 18, 2026</FONT><FONT STYLE="font-size: 10pt">
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deadline
    for delivery of Series B Rights certificates and required documents <BR>
and payment of exercise price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 20, 2026</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration date for Series B Rights </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 20, 2026</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_005"></A>DESCRIPTION
OF SERIES RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The following description summarizes
certain terms of the Series Rights. This description does not purport to be complete and is subject to, and qualified in its entirety
by reference to, the actual terms and provisions of the Series Rights, forms of which are filed as exhibits to the registration
statement of which this prospectus constitutes a part. Prospective investors should carefully review the terms and provisions of the
form of the Series Rights for a complete description of the terms and conditions of the Series Rights. We will provide
copies of the form of this document to you upon request.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duration
and Exercise Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Each Series Right will be a
right to purchase one share of Common Stock and will have an exercise price equal to (i) in the case of a Series A Right, $5.00;
and (ii) in the case of a Series B Right, $6.00. The Series Rights will be issued at the closing of the Unit Subscription
Rights offering which will occur after the expiration date of the Unit Subscription Rights offering. Series A Rights and Series B
Rights may be exercised commencing on their date of issuance and continuing until their applicable expiration dates, respectively,
July 18, 2026 , and November 20, 2026 Each Series Right is subject to the terms of its
respective Series Rights certificate and may only be exercised in accordance with the terms thereof. The Series Rights will be
exercisable on their dates of issuance and will expire on their respective expiration dates.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of Series Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The exercise of Series Rights
is irrevocable and may not be cancelled or modified even if you later learn information that you consider to be unfavorable to the
exercise of your Series Rights, and we will not accept any alternative, conditional or contingent directions. To exercise
Series Rights, Holders should send to (a) the Escrow Agent payment of the exercise price for the Series Rights
being exercised (e.g., $5.00 or $6.00 for each Series A Right, and Series B Right, respectively) which must be
received by the Escrow Agent at or prior to 5:00 p.m., Eastern time, on the applicable expiration date unless the expiration
date is extended by us; and (b) the Subscription Agent a properly completed and duly executed Series Rights
certificate for the applicable Series Rights being exercised along with any required documents, which must be
received by the Subscription Agent at the Subscription Agent&rsquo;s offices set forth herein, at or prior to 5:00
p.m., Eastern time, on the applicable expiration date. A properly completed and duly executed Series Rights certificate for
the Series Rights being exercised and full payment of the initial exercise price must be received by the Subscription
Agent at or prior to 5:00 p.m., Eastern time, on the applicable expiration date unless the expiration date is extended by us. All
payments by a registered holder must be in U.S. dollars by wire transfer to the account maintained by the Escrow Agent for
purposes of accepting the exercise of the Series A Rights and Series B Rights in this offering, with reference to the
registered holder&rsquo;s name. All funds received by the Escrow Agent will be held in a segregated account maintained by the Escrow
Agent on our behalf, pending the closing to occur promptly after the expiration date of each of the respective Series
Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Instruction for Delivery of Forms</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Each Series Rights certificate
and payments of the applicable exercise price (e.g., $5.00 or $6.00 for each Series A Right or Series B Right, respectively)
must be delivered to the Subscription Agent by hand, or overnight courier or by mail to the below:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>If
                                            delivering by hand</U>:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
    Transfer, LLC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
    Lafayette Place</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
    NY 11598</FONT></P></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>If
                                            delivering by mail or overnight courier</U>:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
    Transfer, LLC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
    Lafayette Place</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
    NY 11598</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Subscription Agent can be reached by telephone at (212) 828-8436,
or by email at action@vstocktransfer.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman,serif"><B>Instructions for Payment of Exercise Price.</B></P>

<P STYLE="margin: 0pt; text-align: justify; font: 10pt Times New Roman,serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">You must deliver your payment for
your subscription to the Escrow Agent by wire pursuant to the instructions that will accompany the Unit Subscription Rights certificate and/or the
Series Rights certificates. Personal checks, cashier&rsquo;s check or certified checks will <U>not</U> be accepted. Do not send your
payment to the Subscription Agent or the Company. DO NOT SEND ANY DOCUMENTS TO THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuance
of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The following deliveries and
payments will be made and/or issued to the address shown on the face of your Series Rights certificate, unless you provide instructions
to the contrary in your Series Rights certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As soon as practicable following
the expiration date of each of the Series Rights and the valid exercise of the Series Rights, we will issue to each
holder exercising their Series Rights one share of Common Stock for each Series Right exercised in book-entry, or uncertificated
form representing the shares of Common Stock purchased pursuant to the Series Rights. Shares of Common Stock issuable upon exercise
of the Series Rights will be issued at each of the closing which will occur after the applicable expiration date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B>Delivery of Series Rights through the Depository
Trust Company</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Banks, trust companies, securities dealers
and brokers that hold shares of our Common Stock on the Record Date as nominee for more than one beneficial owner may, upon proper showing
to the Subscription Agent, exercise such beneficial owner&rsquo;s Series Rights through DTC on the same basis as if the
beneficial owners were stockholders on the Record Date. Such nominee may exercise the Series Rights on behalf of the exercising
beneficial owner through DTC: (1) providing a certification as to the aggregate number of Series Rights exercised by the beneficial
owner on whose behalf such nominee is acting to the Subscription Agent, and (2) instructing DTC to charge the nominee&rsquo;s
applicable DTC account for the initial price for the new shares of Common Stock to facilitate the delivery of the full exercise payment
to the Escrow Agent. DTC must receive the subscription instructions and payment for the Series Rights exercised no later
than the applicable expiration date for each of the Series Rights exercised. In the event the transfer agent is not participating
in DTC for the Series Rights, such nominee may exercise the Series Rights on behalf of the exercising beneficial owner
pursuant to the instructions above, and including in such mailing a Series Right Certificate, registered in the Company&rsquo;s
share register in the name of the beneficial owner or its designee, for the number of shares of Common Stock to which the beneficial
owner is entitled pursuant to such exercise.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Validity
of Subscriptions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We will resolve all questions regarding
the validity and form of the exercise of the Unit Subscription Rights and Series Rights, including time of receipt and
eligibility to participate in the offering. In resolving all such questions, we will review the relevant facts, consult with our legal
advisors and we may request input from the relevant parties. Our determination will be final and binding.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fractional
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional Common Stock will be issued upon the exercise of the Series Rights. Rather, the number of shares of Common Stock to
be issued will be rounded down to the nearest whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transferability</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series Rights will be transferable until they have expired. However, the Series Rights are not expected to be listed on
any securities exchange or quoted on any trading market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">There is no trading market available
for the Series Rights on any securities exchange or nationally recognized trading system, and we do not expect a trading market
to develop. We do not intend to list or quote the Series Rights on any securities exchange or nationally recognized trading
market. Without a trading market, the liquidity of the Series Rights will be extremely limited. The Common Stock issuable upon
exercise of the Series Rights will be listed on The Nasdaq Capital Market. The Series Rights will not be listed on any
securities exchange or trading market.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
as a Stockholder</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Except as otherwise provided in the Series
Rights or by virtue of such holder&rsquo;s ownership of Common Stock, the holders of the Series Rights do not have the rights
or privileges of holders of our Common Stock, including any voting rights, until they exercise their Series Rights and are issued
the Common Stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><B>Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Subscription Agent for the
Series Rights will be VStock Transfer, LLC.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of certain U.S. federal income tax considerations relating to the Series Rights, see &ldquo;Material U.S. Federal
Income Tax Considerations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_006"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our capital stock and our current debt agreements preclude us from paying dividends. We
currently intend to retain our future earnings, if any, for use in our business and therefore do not anticipate paying cash dividends
in the foreseeable future. Payment of future dividends, if any, will be at the discretion of our Board of Directors after taking into
account various factors, including our financial condition, operating results, current and anticipated cash needs and plans for expansion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_007"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully
consider the risks described below and discussed under the sections captioned &ldquo;Risk Factors&rdquo; contained in our most recent
Annual Report on Form 10-K, as well as in any of our subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K,
which are incorporated by reference herein in their entirety, together with other information in this prospectus supplement and the accompanying
prospectus, the information and documents incorporated by reference in this prospectus supplement, in the accompanying prospectus and
in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks actually occurs,
our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price of
our securities to decline, resulting in a loss of all or part of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RISKS
RELATED TO THE RIGHTS OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
offering may cause the price of Common Stock to decline, and the price may not recover for a substantial period of time, or at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Unit Subscription Price in this offering,
together with the number of shares of Common Stock we propose to issue and ultimately will issue in the offering (including the number
of additional shares of Common Stock we propose to issue and ultimately will issue upon exercise of the Series Rights), may result
in an immediate decrease in the market value of our Common Stock. We cannot predict the effect, if any, that the availability of shares
for future sale will have on the market price of Common Stock from time to time. General market price declines or market volatility in
the future as a result of the offering could adversely affect the price of our Common Stock, causing the price of our Common Stock to
fluctuate significantly and making it difficult for you to resell your shares of Common Stock when you want or at a price you find attractive.
If the market price of Common Stock falls, you may have irrevocably committed to buy shares of Common Stock in this offering at an effective
price per share greater than the prevailing market price. Further, if a substantial number of Unit Subscription Rights are exercised
and the exercising rights holders choose to sell some or all of the shares purchased either directly or upon the exercise of their Series
Rights, the resulting sales could depress the market price of Common Stock. We cannot assure you that the market price of Common
Stock will not decline prior to the expiration of this offering or that, after shares of Common Stock are issued upon exercise of the
Unit Subscription Rights, you will be able to sell shares of Common Stock purchased in the offering at a price greater than or
equal to the effective price paid in the offering. The Unit Subscription Price may not be indicative of the fair value of Common Stock.
The market price of our Common Stock could decline during or after this offering, and you may not be able to sell shares of Common
Stock purchased in the offering, including shares of Common Stock issuable upon the exercise of the Series Rights, at a price equal to
or greater than the effective price paid in the offering, or at all.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may have</I></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I> material developments during
the subscription period. In considering whether to exercise your Rights, you should consider that all exercises of Unit Subscription
Rights and Series Rights are irrevocable, even if you subsequently learn information about us that you consider to be unfavorable</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently expect that the Unit Subscription Rights will expire if they are not exercised at 5:00 p.m., Eastern time, on December
10, 2025, which we may extend in our sole discretion. The Series A Rights and Series B Rights may be exercised commencing on
their respective date of issuance and continuing until their expiration dates, respectively, July 18, 2026 and November 20, 2026.
The closing for the Series A Rights and the Series B Rights will occur promptly after the applicable expiration dates. We may
have material developments during the Rights Offering. Because all exercises of Rights are irrevocable, you should
therefore consider carefully the timing of your exercise of the Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Unit Subscription Price determined for this offering may not be indicative of the fair value of Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Unit Subscription Price was set by our Board, and you should not consider the Unit Subscription Price as an indication of the fair value
of our Common Stock. The Unit Subscription Price does not necessarily bear any relationship to the book value of our assets, net worth,
past operations, cash flows, earnings/losses, financial condition or any other established criteria for fair value. The market price
of our Common Stock could decline during or after this offering, and you may not be able to sell shares of Common Stock purchased in
the offering, including shares of Common Stock issuable upon the exercise of the Series Rights, at a price equal to or greater
than the effective price paid in the offering, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Your
interest in our Company may be diluted as a result of the offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you do not fully exercise your basic subscription rights or some or all of your Series Rights, you will, at the completion
of this offering, own a smaller proportional interest in our company on a fully diluted basis than would have been the case if you had
fully exercised your basic subscription rights and Series Rights. The magnitude of the reduction of your percentage ownership
will depend upon the extent to which you and others subscribe in the offering. Based on the number of shares outstanding as of October
15, 2025, after giving effect to this offering (assuming the sale of 8,000,000 Units and no exercise of the Series Rights
included in the Units), we would have up to 28,638,095 shares of Common Stock outstanding, representing an increase in outstanding
shares by approximately 39%. Based on the number of shares outstanding as of October 15, 2025, after giving effect to this offering
(assuming the sale of 8,000,000 Units and exercise of all the Series Rights included in the Units), we would have up to 44,638,095 shares
of Common Stock outstanding, representing an increase in outstanding shares by approximately 116%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Units are non-transferable and thus there will be no market for them.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may not sell, transfer or assign your Units to anyone else, unless as required by operation of law. We do not intend to list the Units
on any securities exchange or any other trading market. Because the Units are non-transferable, there is no market or other means for
you to directly realize any value associated with the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>There is no public market for the Unit Subscription
Rights and the Series Rights comprising the Units.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">There is no public trading market for
the Unit Subscription Rights and the Series Rights, and we do not expect a market to develop. We do not intend to list
the respective Unit Subscription Rights and Series Rights on any securities exchange or other trading market. Without an
active market, we cannot assure you that you will be able to sell or otherwise transfer the Unit Subscription Rights or the Series
Rights as the liquidity of the Unit Subscription Rights or Series Rights will be limited and you may not realize any
value from the Unit Subscription Rights or the Series Rights by attempting to sell or otherwise transfer them for consideration.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>Holders of the Series Rights issued in this
offering will have no rights as holders of Common Stock until they exercise their Series Rights and acquire the Common Stock.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Until holders of the Series Rights
issued in this offering acquire the shares of Common Stock upon exercise of such Series Rights, they will have no rights with
respect to the shares of Common Stock issuable upon the exercise of such Series Rights. Upon exercise of the Series Rights
and acquisition of the Common Stock, the holders thereof will be entitled to exercise the rights of the holders of our Common Stock only
as to matters for which the record date occurs after the exercise date of the Series Rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of Common Stock may never exceed the exercise price of the Series Rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Series Rights will be exercisable
commencing on their date of issuance and expire on their respective expiration date. The exercise of the Series Rights is irrevocable
and the closing for the Series Rights will occur after the expiration date of the respective Series Rights. The market price of Common
Stock may never exceed the exercise price of the Series Rights prior to their date of expiration. Any Series Rights not
exercised by their date of expiration will expire without residual value to holders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>During
the period immediately following the expiration of this offering, you may not be able to resell any shares of Common Stock that you purchase
in the offering or upon exercise of your Series Rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If you exercise your Unit Subscription
Rights, you may not be able to resell shares of Common Stock purchased by exercising your Unit Subscription Rights, or shares
of Common Stock issued to you upon the exercise of your Series Rights, until you (or your broker or other nominee) have received
a book-entry representing the underlying shares. Although we will endeavor to issue the book entries promptly, there may be some delay
between the applicable expiration date of the Unit Subscription Rights and the Series Rights and the time that we issue
the book-entry statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, to the extent you are an affiliate, as defined in Rule 144 under the Securities Act, the resale of shares of Common Stock by
you will be subject to certain restrictions, including volume limitations, under Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have broad discretion in the use of the net proceeds of this offering and, despite our efforts, we may use the proceeds in a manner that
neither improves our operating results nor increases the value of your investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B><I>&nbsp;</I></FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">We currently anticipate
that the net proceeds from the offering will be used primarily for scaling domestic manufacturing and operations; advancing R&amp;D
and product commercialization; deepening vertical integration and supply-chain resilience; engaging in strategic partnerships; supporting
corporate growth initiatives, and working capital and general corporate purposes. However, we have not determined the specific allocation
of the net proceeds among these potential uses. Our management will have broad discretion over the use and use of the net proceeds of
this offering, and, accordingly, investors in this offering will need to rely upon the judgment of our management with respect to the
use of proceeds, with only limited information concerning our specific intentions. These proceeds could be applied in ways that do not
improve our operating results or increase the value of your investment. Please see the section entitled &ldquo;Use of Proceeds&rdquo;
on page S-25 for further information.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we terminate this offering, neither we, the Subscription Agent nor the Escrow Agent will have any obligation to you except to promptly
return your subscription payments, without interest.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may terminate this offering at any time. If we do, neither we, the Subscription Agent nor the Escrow Agent for the
offering will have any obligation to you other than to promptly return, without interest or deduction, the subscription payment you
delivered to the Escrow Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you do not act on a timely basis and follow subscription instructions, your exercise of Unit Subscription Rights being distributed
or the Series Rights may be rejected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Holders of Common Stock and Eligible
Warrantholders who desire to exercise their Unit Subscription Rights to purchase Units in this offering must act on a timely
basis to ensure that all required forms are actually received by the Subscription Agent and payments are actually received by the Escrow
Agent prior to 5:00 p.m., Eastern time, on the expiration date of the Series Rights Offering. Holders who wish to exercise their
Series Rights to purchase shares of Common Stock must act on a timely basis to ensure that all required forms are actually
received by the Subscription Agent and exercise payments are actually received by the Escrow Agent prior to 5:00 p.m., Eastern
time, on the applicable expiration date of the respective Series Rights. If you are a beneficial owner of shares of Common Stock
and you wish to exercise your Unit Subscription Rights being distributed or Series Rights comprising the Units, you must
act promptly to ensure that your broker, custodian bank or other nominee (including any mobile investment platform) acts for you and
that all required forms and payments are actually received by your broker, custodian bank or other nominee (including any mobile investment
platform) in sufficient time to deliver such forms (i) to the Subscription Agent, and (ii) payments to the Escrow Agent in order
to exercise your Unit Subscription Rights or Series Rights, by 5:00 p.m., Eastern time, on the applicable expiration date.
We will not be responsible if your broker, custodian or nominee (including any mobile investment platform) fails to ensure that all required
forms are actually received by the Subscription Agent; and payments are actually received by the Escrow Agent in a timely manner.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If you fail to complete, sign and delivery
the required subscription forms to the Subscription Agent, send an incorrect payment amount to the Escrow Agent, or otherwise fail to
follow the subscription procedures that apply to your exercise of the Unit Subscription Rights and Series Rights, the Subscription
Agent may, depending on the circumstances, reject your subscription or accept it only to the extent of the payment received. Neither
we nor the Subscription Agent, or Escrow Agent undertake to contact you concerning an incomplete or incorrect subscription form or payment,
nor are we, the Subscription Agent, or the Escrow Agent under any obligation to correct such forms or payment. We have
the sole discretion to determine whether an exercise properly follows the subscription procedures.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>You may not receive all of the Units for
which you subscribe pursuant to your Unit Subscription Rights.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Your exercise of your Unit Subscription Rights may not result in the issuance
of any Units. Although we intend to honor all properly exercised Unit Subscription Rights, there are circumstances pursuant to which you
may not receive any Units upon exercising such rights. These circumstances include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><I>&#9679; Invalid or late
subscription</I>: Failure to properly complete or timely submit the Unit Subscription documents to
the Subscription Agent, or failure to remit the full Unit Subscription Price to the Escrow Agent in accordance with the terms of the offering
and the instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#9679; <I>Termination or
cancellation of the offering</I>: We may, in our discretion or due to market or regulatory conditions, terminate or cancel the Rights
Offering prior to issuance of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#9679; <I>Minimal ownership</I>:
Due to the maximum of 8,000,000 Units in the aggregate issuable pursuant to
Unit Subscription Rights, basic subscription rights may be pro-rated based on the number
of basic subscription rights subscribed and subscribers that were not issued many Unit Subscription Rights or don&rsquo;t subscribe for
many Units pursuant to the basic subscription rights may not receive any Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In any such case, any payments
made in connection with your subscription will be returned without interest, and you may not receive any shares even though you exercised
your rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may not receive all of the Units for which you subscribe under the oversubscription privilege.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Holders who fully exercise their basic subscription
rights will have the right, pursuant to their oversubscription privilege, to purchase additional Units to the extent Units are
available. Units subscribed pursuant to the oversubscription privilege will be allocated pro rata among participating rights
holders in proportion to the number of oversubscription Units for which they subscribed. We cannot guarantee that you will
receive all, or a significant portion, of the Units for which you subscribe pursuant to your oversubscription privilege. All
basic subscription rights exercised will be honored first and the oversubscription privilege will be honored second.
If the number of Units allocated to you is less than your subscription request, the excess funds held by the Escrow Agent on
your behalf will be promptly returned to you, without interest or deduction, after the closing of the Unit Subscription
Offering, and we will have no further obligations to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Your
receipt of Unit Subscription Rights may be treated as a taxable dividend to you.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax law governing transactions such as this offering is complex and does not speak directly to the consequences of
certain aspects of the offering. Although we do not believe a stockholder&rsquo;s receipt of Unit Subscription Rights pursuant
to the offering should be treated as a taxable distribution for U.S. federal income tax purposes, our position is not binding on the
IRS or the courts. If this position were finally determined by the IRS or a court to be incorrect, your receipt of Unit Subscription
Rights may be treated as the receipt of a distribution equal to the fair market value of the rights, and may result in taxable dividend
income to the extent of our current and accumulated earnings and profits, with any excess being treated as a return of basis to the extent
thereof and then as capital gain. See &ldquo;Material U.S. Federal Income Tax Considerations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Moody
Capital, as dealer-manager, is not acting as an underwriter</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Moody Capital will act as dealer-manager
for this offering and, in that capacity, will provide marketing assistance in connection with this offering. Moody Capital is not underwriting
this offering. Moody is not making any recommendation with respect to such Unit Subscription Rights (including with respect to
the exercise or expiration of such Unit Subscription Rights), shares of Common Stock or Series Rights. Moody Capital will
not be subject to any liability in rendering services except for an act involving bad faith, willful misconduct or gross
negligence.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because</I></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>
we do not have a standby purchase agreement, backstop commitment or similar arrangement in connection with this offering, the net proceeds
we receive from the offering may be less than we intend.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have currently not entered
into any standby purchase agreement, backstop commitment or similar arrangement in connection with this offering. We therefore cannot
assure you that any of our stockholders will exercise all or any part of their Unit Subscription Rights. If rights holders subscribe
for fewer Units than anticipated, the net proceeds we receive from this offering could be significantly reduced. Regardless of whether
this offering is fully subscribed or we do enter into a standby purchase agreement, backstop commitment or similar arrangement, we may
need to raise additional capital in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may in the future enter into a standby purchase agreement, backstop commitment or similar arrangement in connection with this offering
if we are able to negotiate commercially reasonable terms with a standby purchaser or backstop purchaser. We cannot assure you that such
an arrangement will be available on commercially reasonable terms and if we are unable to negotiate commercially reasonable terms for
a standby purchase agreement, backstop commitment or similar arrangement in connection with this offering we would not enter into such
an arrangement. In the event we enter into a standby purchase agreement, backstop commitment or similar arrangement in connection with
this offering we will file a Current Report on Form 8-K with a summary of the terms of such arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B><I>Because you may not revoke or change your exercise
of the Unit Subscription Rights and Series Rights, you could be committed to buying shares above the prevailing market price
at the time this offering is completed.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Once you exercise your Unit
Subscription Rights and Series Rights, you may not revoke or change the exercise. The market price of our Common Stock may
decline before the expiration date and closing of the Unit Subscription Rights and, subsequently, the closing of each Series
Rights Offering. Each of the closings for the Unit Subscription Rights and the Series Rights will occur after the applicable
expiration date.  If you exercise your Unit Subscription Rights or Series Rights, and, afterwards, the market
price of our Common Stock decreases below the Unit Subscription Price or the applicable exercise price for the Series Right,
you will have committed to buying shares of our Common Stock at a price above the prevailing market price and could have an
immediate unrealized loss.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Common Stock is traded on The Nasdaq
Capital Market under the symbol &ldquo;AMPG.&rdquo; The closing price of the Common Stock on October 29, 2025 was $3.64
per share. There can be no assurances that the market price of our Common Stock will equal or exceed the Unit Subscription Price or
the exercise price for the Series Rights at the time of exercise or at the expiration of this offering.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
the Series Rights are executory contracts, they may have no value in a bankruptcy or reorganization proceeding.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event a bankruptcy or reorganization proceeding is commenced by or against us, a bankruptcy court may hold that any then-unexercised
Series Rights are executory contracts subject to rejection by us with the approval of a bankruptcy court. As a result, even if
we have sufficient funds, holders may not be entitled to receive any consideration for their Series Rights or may receive an amount
less than they would be entitled to if they had exercised their Series Rights prior to the commencement of any such bankruptcy
or reorganization proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not intend to pay any cash dividends on our Common Stock in the foreseeable future and, therefore, any return on your investment in
our Common Stock must come from increases in the fair market value and trading price of our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to pay any cash dividends on our Common Stock in the foreseeable future and, therefore, any return on your investment in
our Common Stock must come from increases in the fair market value and trading price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_008"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
the sale of all offered Units and no exercise of Series A Rights and Series B Rights and based on the 8,000,000
maximum number of Units available for issuance in this offering, we estimate our net proceeds from the offering will total approximately
$29,383,500, after deducting fees and expenses of Moody Capital, as dealer-manager, and our other estimated offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds from this offering, including any additional net proceeds from the exercise of the Series Rights to
scale domestic manufacturing and operations; advance R&amp;D and product commercialization; deepen vertical integration and supply-chain
resilience; engage in strategic partnerships; and support corporate growth initiatives; and for working capital and general corporate
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">At this time, management has not determined
the specific allocation of use of proceeds which allocations will depend on many factors including the amount raised from this offering.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay estimated expenses of approximately $376,500, excluding dealer-manager fees, in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may find it necessary or advisable to use the net proceeds for other purposes, and we will have broad discretion in the application of
the net proceeds. Pending the uses described above, we may invest the net proceeds from this offering in investment-grade, interest-bearing
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_009"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">As soon as practicable after 5:00 p.m.,
Eastern time, on November 10, 2025, the Record Date for this Rights Offering, we will distribute the Unit Subscription Rights
and Unit Subscription Rights certificates to persons who owned settled shares of Common Stock or certain eligible warrants at
5:00 p.m., Eastern time, on the Record Date. Unit Subscription Rights being distributed and the Series Rights comprising
the Units may be exercised by completing and signing the Unit Subscription Rights certificate or Series Rights certificate
that accompanies this prospectus supplement and mailing it in the envelope provided, or otherwise delivering the completed and duly executed
Unit Subscription Rights certificate or Series Rights certificate to the Subscription Agent, together with payment in full
delivered to the Escrow Agent before the applicable expiration date. The offering of Unit Subscription Rights will expire
at 5:00 p.m., Eastern time, on December 10, 2025, unless extended or terminated by us, and Unit Subscription Rights may
not be exercised after the expiration date. Series A Rights and Series B Rights may be exercised commencing on their respective
date of issuance and continuing until their expiration dates, respectively, July 18, 2026 and November 20, 2026.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;The Rights Offering&rdquo; for instructions on exercising Unit Subscription Rights and Series Rights. If you have any questions
or need further information about this offering, please contact MacKenzie Partners Inc., the information agent, by telephone by
telephone at (212) 929-5500 (bankers and brokers) or (800) 322-2885 (all others) or by email at AMPG@mackenziepartners.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dealer-Manager</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moody
Capital is the dealer-manager of this offering and, under the terms and subject to the conditions contained in its dealer-manager
agreement with us, Moody Capital will provide marketing assistance and advice to us in connection with the offering. Moody Capital
will not make a market in the Rights. We have currently not entered into any standby purchase agreement, backstop commitment or
similar arrangement in connection with this offering</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay Moody Capital a cash fee equal to 7.0% of the proceeds of the offering from the exercise of the Unit Subscription
Rights and the Series Rights; provided however, if the aggregate subscription proceeds equal more than $10 million but less than $20
million, we have agreed to pay Moody Capital a cash fee equal to 6.0%; provided further, if the aggregate subscription proceeds
equal less than $10 million, we have agreed to pay Moody Capital a cash fee equal to 5.0%. We also paid Moody Capital an
out-of-pocket accountable expense allowance of $35,000. If all Unit Subscription Rights are exercised and no Series Rights are
exercised, Moody Capital&rsquo;s dealer-manager fee would equal $2,240,000, and if all Unit Subscription Rights and all Series
Rights are exercised, Moody Capital&rsquo;s dealer-manager fee would equal $8,400,000. No assurance can be given that shareholders
and Eligible Warrantholders will exercise the maximum Unit Subscription Rights and Series Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify Moody Capital and its affiliates against, or contribute to losses arising out of, certain liabilities, including
liabilities under the Securities Act. Moody Capital&rsquo;s participation in this offering is subject to customary conditions contained
in the dealer-manager agreement. The dealer-manager agreement provides that the dealer-manager will not be subject to any liability in rendering the services contemplated by the dealer-manager agreement, except for any act of bad faith, willful misconduct
or gross negligence of the dealer-manager. The dealer-manager and its affiliates may provide us from time to time in the future in the
ordinary course of its business certain financial advisory, investment banking and other services for which it will be entitled to receive
customary fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum commission to be received by any independent broker-dealer, dealer-manager or any member of FINRA will not be greater than 8.0%
of the gross proceeds from the exercise of Unit Subscription Rights in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as described herein, we do not know of any existing agreements between or among any stockholder, broker, dealer, underwriter or
agent relating to the sale or distribution of the underlying shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our officers, employees and directors may solicit responses from the holders of Unit Subscription Rights. None of our officers,
directors or employees will be compensated in connection with these actions by the payment of commissions or other remuneration based
either directly or indirectly on the subscriptions but will be reimbursed for reasonable expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay the Subscription Agent and the Information Agent customary fees plus certain expenses in connection
with the offering. Except as described in this section, we are not paying any commissions, underwriting fees or discounts in connection
with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying prospectus may be made available in electronic format on websites or via email or through
other online services maintained by Moody Capital or us. Other than this prospectus supplement and the accompanying prospectus in electronic
format, the information on our and Moody Capital&rsquo;s websites is not part of this prospectus supplement or the registration statement
of which this prospectus supplement forms a part, has not been approved or endorsed by us or Moody Capital, and should not be relied
upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not purport to be a complete statement of the terms and conditions of the dealer-manager agreement between Moody Capital
and us. A copy of the dealer-manager agreement will be filed as an exhibit to our Current Report on Form 8-K. See &ldquo;Where You Can
Find Additional Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
M Restrictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moody
Capital, as dealer-manager, may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any
fees received by it might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, Moody Capital
would be required to comply with the requirements of the Securities Act and the Exchange Act, including Rule 10b-5 and Regulation M under
the Exchange Act. These rules and regulations may limit the timing of any purchases and sales of securities by Moody Capital acting as
a principal. Under these rules and regulations, Moody Capital must not engage in any stabilization activity in connection with our securities
and must not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than
as permitted under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
Stabilization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized any person to engage in any form of price stabilization in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_010"></A>MATERIAL
U.S. FEDERAL INCOME TAX CONSIDERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The following discussion is a summary
of the material U.S. federal income tax considerations with respect to the receipt and exercise (or expiration) of the Unit Subscription
Rights and Series Rights, and of the ownership and disposition of shares of Common Stock acquired upon exercise of such rights,
but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate
and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), Treasury Regulations promulgated thereunder, judicial decisions, and published
rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;), in each case in effect as of
the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation
may be applied retroactively in a manner that could adversely affect a holder of the Unit Subscription Rights, Series Rights or
shares of Common Stock. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can
be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the receipt
or exercise of Unit Subscription Rights, the exercise of Series Rights acquired through this offering nor the acquisition,
ownership or disposition of Common Stock acquired upon exercise of any such rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion is limited to stockholders that hold the Unit Subscription Rights, Series Rights and shares of Common Stock,
in each case, as a &ldquo;capital asset&rdquo; within the meaning of Section 1221 of the Code (generally, property held for investment).
This discussion does not address all U.S. federal income tax considerations relevant to a holder&rsquo;s particular circumstances, including
the impact of the alternative minimum tax (including the alternative minimum tax imposed on corporations with respect to financial statement
income) or the unearned income Medicare contribution tax. In addition, it does not address consequences relevant to holders subject to
particular rules, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
                                            expatriates and former citizens or long-term residents of the United States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">persons
                                            holding the Unit Subscription Rights, Series Rights or shares of Common Stock
                                            as part of a hedge, straddle, wash sale or other risk reduction strategy or as part of a
                                            conversion transaction or other integrated investment;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks,
                                            insurance companies, and other financial institutions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers,
                                            dealers or traders in securities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;controlled
                                            foreign corporations,&rdquo; &ldquo;passive foreign investment companies,&rdquo; and corporations
                                            that accumulate earnings to avoid U.S. federal income tax;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">entities
                                            or arrangements treated as partnerships for U.S. federal income tax purposes (and investors
                                            therein);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
                                            organizations or governmental organizations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">persons
                                            deemed to sell Series Rights or shares of Common Stock under the constructive sale
                                            provisions of the Code;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">persons
                                            subject to special tax accounting rules as a result of any item of gross income with respect
                                            to the Unit Subscription Rights, Series Rights or shares of Common Stock being
                                            included in an &ldquo;applicable financial statement&rdquo; (as defined in the Code);</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            for whom our capital stock constitutes &ldquo;qualified small business stock&rdquo; within
                                            the meaning of Section 1202 of the Code;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">persons
                                            who hold or receive the Unit Subscription Rights, Series Rights or shares of
                                            Common Stock pursuant to the exercise of any employee stock option or otherwise as compensation;
                                            and</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-qualified
                                            retirement plans.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a holder is treated as a partnership for U.S. federal income tax purposes, the tax treatment of a partner in the partnership will depend
on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships
and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><B>THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS
NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR
PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE RECEIPT, OWNERSHIP AND EXERCISE OF UNIT SUBSCRIPTION RIGHTS AND SERIES
RIGHTS AND THE SHARES OF COMMON STOCK ACQUIRED UPON EXERCISE OF SUCH RIGHTS ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS
OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
Considerations Applicable to U.S. Holders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Definition
of a U.S. Holder</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For purposes of this discussion,
a &ldquo;U.S. holder&rdquo; is any beneficial owner of Unit Subscription Rights, shares of Common Stock, the Series Rights
acquired upon exercise of Unit Subscription Rights, or shares of Common Stock acquired upon exercise of the Series Rights,
as the case may be, that is, for U.S. federal income tax purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual who is a citizen or resident of the United States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation (or other entity treated as a corporation for U.S. federal income tax purposes)
                                            created or organized under the laws of the United States, any state thereof, or the District
                                            of Columbia;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate, the income of which is subject to U.S. federal income tax regardless of its source;
                                            or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust that (a) is subject to the primary supervision of a U.S. court and the control of one
                                            or more United States persons (within the meaning of Section 7701(a)(30) of the Code), or
                                            (b) has made a valid election under applicable Treasury Regulations to continue to be treated
                                            as a United States person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Receipt of Unit Subscription Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
305(a) of the Code states that a corporate stockholder&rsquo;s taxable income generally does not include a distribution of stock in the
corporation. This general non-recognition rule is, however, subject to exceptions described in Section 305(b) of the Code, which include,
among other things, &ldquo;disproportionate distributions&rdquo; and certain distributions with respect to certain preferred stock. A
disproportionate distribution is a distribution (or a series of distributions, including deemed distributions), that has the effect of
the receipt of cash or other property by some stockholders (including holders of rights to acquire stock and holders of debt instruments
convertible into stock), and an increase in the proportionate interest of other stockholders (including holders of rights to acquire
stock and holders of debt instruments convertible into stock) in a corporation&rsquo;s assets or earnings and profits. For this purpose,
if a distribution of stock to some stockholders and the receipt of cash and other property by other stockholders are separated by more
than 36 months, the transactions are presumed not to result in the receipt of cash or other property by some stockholders and an increase
in the proportionate interest of other stockholders, unless the transactions are done pursuant to a plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<BR>
</FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the last 36 months, we have not made any distributions of cash or property, and during this period we did not have any convertible debt
instruments. Therefore, whether this offering is treated as a disproportionate distribution may depend upon, among other things, whether
we make distributions on our stock in the future and the timing of such distributions. We do not intend to make any future distributions
of cash or other property with respect to our Common Stock, but no assurances can be offered in this regard.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Based on the above, although the authorities
governing transactions such as this offering are complex and do not speak directly to the consequences of certain aspects of the offering,
including the effects of the oversubscription privilege, we do not believe that a U.S. holder&rsquo;s receipt of Unit Subscription
Rights pursuant to the offering should be treated as a taxable distribution for U.S. federal income tax purposes. Our position regarding
the tax-free treatment of the receipt of Unit Subscription Rights is not binding on the IRS or the courts. If this position were
finally determined by the IRS or a court to be incorrect, whether on the basis that the issuance of the Unit Subscription Rights
is a &ldquo;disproportionate distribution&rdquo; or otherwise, the receipt of the Unit Subscription Rights would be taxable generally
in the same manner as described under &ldquo;Tax Considerations Applicable to U.S. Holders - Distributions on Common Stock&rdquo;
below, with the amount of the distribution calculated as the fair market value of the Unit Subscription Rights. In addition, other
U.S. federal income tax consequences applicable to U.S. holders such as the tax basis and holding period of the Unit Subscription
Rights and our Common Stock may also be materially different from the discussion below.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The following discussion is based upon
the assumption that the Unit Subscription Rights issuance is treated as a non-taxable distribution for U.S. federal income tax
purposes.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Tax Basis and Holding Period in the Unit Subscription Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If the fair market value of the Unit
Subscription Rights a U.S. holder receives is less than 15% of the fair market value of the U.S. holder&rsquo;s existing shares of
Common Stock with respect to which the Unit Subscription Rights are distributed on the date the U.S. holder receives the Unit
Subscription Rights, the Unit Subscription Rights will be allocated a zero tax basis for U.S. federal income tax purposes,
unless the U.S. holder elects to allocate its tax basis in its existing shares of stock between such existing shares of stock and such
Unit Subscription Rights in proportion to the relative fair market values of the existing shares of stock and the Unit Subscription
Rights determined on the date of receipt of the Unit Subscription Rights. If a U.S. holder chooses to allocate tax basis between
its existing shares of stock and the Unit Subscription Rights, the U.S. holder must make this election on a statement included
with its timely filed tax return (including extensions) for the taxable year in which the U.S. holder receives the Unit Subscription
Rights. Such an election is irrevocable. Furthermore, a U.S. holder who makes such an election must retain a copy of the election,
and of the tax return with which it was filed, in order to substantiate the use of an allocated basis upon a subsequent disposition of
any of the holder&rsquo;s stock, the basis of which was affected by the allocation.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If the fair market value of the Subscription
Rights a U.S. holder receives is 15% or more of the fair market value of such holder&rsquo;s shares of stock on the date the U.S. holder
receives the Unit Subscription Rights, however, then the U.S. holder must allocate its tax basis in its existing shares of stock
between those shares and the Unit Subscription Rights the U.S. holder receives in proportion to the relative fair market values
of such shares and such Unit Subscription Rights determined on the date the U.S. holder receives the Unit Subscription Rights.
The holding period of Unit Subscription Rights received will include a holder&rsquo;s holding period in shares of stock with respect
to which the Unit Subscription Rights were distributed.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair market value of the Unit
Subscription Rights on the date that the Unit Subscription Rights are distributed is uncertain, and we have not obtained,
and do not intend to obtain, an appraisal of the fair market value of the Unit Subscription Rights on that date. In determining
the fair market value of the Unit Subscription Rights, U.S. holders should consider all relevant facts and circumstances, including
any difference between the Unit Subscription Price of the Unit Subscription Rights and the trading price of Common Stock on the
date that the Unit Subscription Rights are distributed, the exercise prices of each Series Right, the length of
the period during which the Unit Subscription Rights may be exercised and the transferability of the Unit Subscription
Rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Exercise of Unit Subscription Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Generally, a U.S. holder will not recognize
gain or loss upon the exercise of a Unit Subscription Right received in this offering. A U.S. holder&rsquo;s adjusted tax basis,
if any, in the Unit Subscription Right plus the Unit Subscription Price paid in respect of such exercise should be allocated between
the new shares of Common Stock and the Series Rights acquired upon exercise of the Unit Subscription Right in proportion
to their relative fair market values on the exercise date. This allocation will establish the U.S. holder&rsquo;s initial tax basis for
U.S. federal income tax purposes in the new shares of Common Stock and Series Rights received upon exercise. A U.S. holder&rsquo;s
holding period for a share of Common Stock and any Series Rights acquired upon exercise of a Unit Subscription Right in
this offering will begin on the date of exercise.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If, at the time of the receipt or exercise
of the Unit Subscription Right, the U.S. holder no longer holds the stock with respect to which the Unit Subscription Right
was distributed, then certain aspects of the tax treatment of the receipt and exercise of the Unit Subscription Right are unclear,
including (1) the allocation of the tax basis between the shares of stock previously sold and the Unit Subscription Right, (2)
the impact of such allocation on the amount and timing of gain or loss recognized with respect to the shares of stock previously sold,
and (3) the impact of such allocation on the tax basis of the shares of stock and Series Rights acquired upon exercise of the
Unit Subscription Right. If a U.S. holder exercises a Unit Subscription Right received in this offering after disposing
of shares of Common Stock with respect to which the Unit Subscription Right is received, the U.S. holder should consult its tax
advisor.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Expiration of Unit Subscription Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If a U.S. holder that receives Unit
Subscription Rights in this offering allows such Unit Subscription Rights to expire, the U.S. holder should not recognize
any gain or loss for U.S. federal income tax purposes, and the U.S. holder should re-allocate any portion of the tax basis in its existing
shares of stock previously allocated to the expired Unit Subscription Rights to the existing shares of stock. If a U.S. holder
allows a Unit Subscription Right received in this offering to expire after disposing of shares of Common Stock with respect to
which the Unit Subscription Right is received, the U.S. holder should consult its tax advisor.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Exercise or Expiration of the Series Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">In general, a U.S. holder will not be
required to recognize income, gain or loss upon exercise of a Series Right for its exercise price. A U.S. holder&rsquo;s tax basis
in a share of Common Stock received upon exercise of the Series Rights will be equal to the sum of (1) the U.S. holder&rsquo;s
tax basis in the Series Rights exchanged therefor and (2) the exercise price of such Series Rights. A U.S. holder&rsquo;s
holding period for a share of Common Stock acquired upon exercise of any Series Rights will begin on the date of exercise.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If a Series Right expires without
being exercised, a U.S. holder will recognize a capital loss in an amount equal to such holder&rsquo;s tax basis in the Series Rights.
Such loss will be long-term capital loss if, at the time of the expiration, the U.S. holder&rsquo;s holding period in such Series
Rights is more than one year. The deductibility of capital losses is subject to certain limitations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B><I>Constructive Dividends on Series Rights</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">If at any time during the period in which
a U.S. holder holds Series Rights, we were to pay a taxable dividend to our stockholders and the exercise price of the Series
Rights were decreased, that decrease would be deemed to be the payment of a taxable dividend to a U.S. holder of the Series Rights
to the extent of our current or accumulated earnings and profits as determined under U.S. federal income tax principles, notwithstanding
the fact that such U.S. holder will not receive a cash payment. If the exercise price is adjusted in certain other circumstances (or
in certain circumstances, there is a failure to make an adjustment), such adjustments may also result in the deemed payment of a taxable
dividend to a U.S. holder. U.S. holders should consult their tax advisors regarding the proper treatment of any adjustments to the exercise
price of the Series Rights.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: sp_01 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Distributions
on Common Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not anticipate declaring or paying cash dividends to holders of our Common Stock in the foreseeable future. However, if we make distributions
of cash or property on Common Stock, such distributions will constitute dividends to the extent paid out of our current or accumulated
earnings and profits, as determined under U.S. federal income tax principles. A corporate U.S. holder receiving a dividend may be eligible
to claim a dividend received deduction, subject to applicable limitations. Dividends received by certain non-corporate U.S. holders,
including individuals, are generally taxed at the lower applicable capital gains rate provided certain holding period and other requirements
are satisfied. Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital and first
be applied against and reduce a U.S. holder&rsquo;s adjusted tax basis in its Common Stock, but not below zero. Any excess will be treated
as capital gain and will be treated as described in the section immediately below relating to the sale or disposition of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sale,
Exchange or Other Disposition of Common Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a sale, exchange, or other disposition of Common Stock, a U.S. holder generally will recognize capital gain or loss equal to the difference
between the amount realized (not including any amount attributable to declared and unpaid dividends, which will be taxable as described
above to U.S. holders of record who have not previously included such dividends in income) and the U.S. holder&rsquo;s adjusted tax basis
in Common Stock. A U.S. holder&rsquo;s adjusted tax basis in Common Stock generally will equal its initial tax basis in Common Stock
reduced by the amount of any cash distributions treated as a return of capital as described above. Such capital gain or loss generally
will be long-term capital gain or loss if the U.S. holder&rsquo;s holding period for Common Stock exceeded one year at the time of disposition.
Long-term capital gains recognized by certain non-corporate U.S. holders, including individuals, generally are subject to reduced rates
of taxation. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Medicare Tax on Net Investment Income</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
additional 3.8% tax (the &ldquo;Medicare Tax&rdquo;) will be imposed on the &ldquo;net investment income&rdquo; of certain U.S. citizens
and resident aliens, and on the undistributed &ldquo;net investment income&rdquo; of certain estates and trusts, with &ldquo;modified
adjusted gross income&rdquo; in excess of threshold amounts. Among other items, &ldquo;net investment income&rdquo; generally includes
gross income from dividends and net gain from the disposition of property, such as our capital stock, less certain deductions. U.S. Holders
should consult their tax advisor about the Medicare Tax.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Reporting and Backup Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. holder may be subject to information reporting and backup withholding when such holder receives dividend payments or receives proceeds
from the sale or other taxable disposition of shares of Common Stock acquired through exercise of the Series Rights. Certain U.S.
holders are exempt from backup withholding, including corporations and certain tax-exempt organizations. A U.S. holder will be subject
to backup withholding if such holder is not otherwise exempt and such U.S. holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fails
                                            to furnish such U.S. holder&rsquo;s taxpayer identification number;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">furnishes
                                            an incorrect taxpayer identification number;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            notified by the IRS that such U.S. holder previously failed to properly report payments of
                                            interest or dividends; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fails
                                            to certify under penalties of perjury that such U.S. holder has furnished a correct taxpayer
                                            identification number and that the IRS has not notified the holder that such U.S. holder
                                            is subject to backup withholding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit
against a U.S. holder&rsquo;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. U.S.
holders should consult their tax advisors regarding their qualification for an exemption from backup withholding and the procedures for
obtaining such an exemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Considerations Applicable to Non-U.S. Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For purposes of this discussion,
a &ldquo;non-U.S. holder&rdquo; is any beneficial owner of Unit Subscription Rights, shares of Common Stock and the Series
Rights acquired upon exercise of Unit Subscription Rights, or shares of Common Stock acquired upon exercise of the Series
Rights, as the case may be, that is neither a U.S. holder nor an entity or arrangement treated as a partnership for U.S. federal
income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The discussion assumes that
the receipt of Unit Subscription Rights with respect to existing shares of Common Stock will be treated as a nontaxable distribution.
See &ldquo;&mdash; Tax Considerations Applicable to U.S. Holders &mdash; Receipt of Unit Subscription Rights&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Receipt,
Exercise and Expiration of the Unit Subscription Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
holders that receive Unit Subscription Rights with respect to existing shares of Common Stock will generally not be subject to
U.S. federal income tax (or any withholding thereof) on the receipt, exercise or expiration of the Unit Subscription Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of the Series Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. holder generally will not be subject to U.S. federal income tax on the exercise of the Series Rights into shares of Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Constructive
Dividends on Series Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time during the period in which a non-U.S. holder holds Series Rights we were to pay a taxable dividend to our stockholders
and the exercise price of the Series Rights were decreased, that decrease would be deemed to be the payment of a taxable dividend
to a non-U.S. holder to the extent of our current and accumulated earnings and profits as determined under U.S. federal income tax principles,
notwithstanding the fact that such non-U.S. holder will not receive a cash payment, and treated as set forth below in &ldquo;&mdash;Distributions
on Common Stock&rdquo;. If the exercise price is adjusted in certain other circumstances (or in certain circumstances, there is a failure
to make an adjustment), such adjustments may also result in the deemed payment of a taxable dividend to a non-U.S. holder. Any resulting
withholding tax attributable to deemed dividends may be collected from other amounts payable or distributable to, or other assets of,
the non-U.S. holder. Non-U.S. holders should consult their tax advisors regarding the proper treatment of any adjustments to the Series
Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
on Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not anticipate declaring or paying cash dividends to holders of our Common Stock in the foreseeable future. However, if we make distributions
of cash or property on Common Stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent
paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated
as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a non-U.S.
holder&rsquo;s adjusted tax basis in its Common Stock, as the case may be, but not below zero. Any excess will be treated as capital
gain and will be treated as described below in the section relating to the sale or disposition of Common Stock. Because we may not know
the extent to which a distribution is a dividend for U.S. federal income tax purposes at the time it is made, for purposes of the withholding
rules discussed below we or the applicable withholding agent may treat the entire distribution as a dividend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below on backup withholding and foreign accounts, dividends paid to a non-U.S. holder of Common Stock that are not
effectively connected with the non-U.S. holder&rsquo;s conduct of a trade or business within the United States will be subject to U.S.
federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax
treaty).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
holders will be entitled to a reduction in or an exemption from withholding on dividends as a result of either (a) an applicable income
tax treaty or (b) the non-U.S. holder holding Common Stock in connection with the conduct of a trade or business within the United States
and dividends being effectively connected with that trade or business. To claim such a reduction in or exemption from withholding, the
non-U.S. holder must provide the applicable withholding agent with a properly executed (a) IRS Form W-8BEN or W-8BEN-E (or other applicable
documentation) claiming an exemption from or reduction of the withholding tax under the benefit of an income tax treaty between the United
States and the country in which the non-U.S. holder resides or is established, or (b) IRS Form W-8ECI stating that the dividends are
not subject to withholding tax because they are effectively connected with the conduct by the non-U.S. holder of a trade or business
within the United States, as may be applicable. These certifications must be provided to the applicable withholding agent prior to the
payment of dividends and must be updated periodically. Non-U.S. holders that do not timely provide the applicable withholding agent with
the required certification, but that qualify for a reduced rate under an applicable income tax treaty, may obtain a refund of any excess
amounts withheld by timely filing an appropriate claim for refund with the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
dividends paid to a non-U.S. holder are effectively connected with the non-U.S. holder&rsquo;s conduct of a trade or business within
the United States (and, if required by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment or fixed
base in the United States to which such dividends are attributable), then, although exempt from U.S. federal withholding tax (provided
the non-U.S. holder provides appropriate certification, as described above), the non-U.S. holder will be subject to U.S. federal income
tax on such dividends on a net income basis at the regular graduated U.S. federal income tax rates. In addition, a non-U.S. holder that
is a corporation may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty)
on its effectively connected earnings and profits for the taxable year that are attributable to such dividends, as adjusted for certain
items. Non-U.S. holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale
or Other Disposition of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussions below on backup withholding and foreign accounts, a non-U.S. holder will not be subject to U.S. federal income tax
on any gain recognized upon the sale or other taxable disposition of Common Stock unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            gain is effectively connected with the non-U.S. holder&rsquo;s conduct of a trade or business
                                            within the United States (and, if required by an applicable income tax treaty, the non-U.S.
                                            holder maintains a permanent establishment or fixed base in the United States to which such
                                            gain is attributable);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            non-U.S. holder is a nonresident alien individual present in the United States for 183 days
                                            or more during the taxable year of the disposition and certain other requirements are met;
                                            or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock constitutes a U.S. real property interest (&ldquo;USRPI&rdquo;), by reason of our status
                                            as a U.S. real property holding corporation (&ldquo;USRPHC&rdquo;), for U.S. federal income
                                            tax purposes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular graduated
rates. A Non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified
by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified
by an applicable income tax treaty) on any gain derived from the disposition, which may be offset by U.S. source capital losses of the
non-U.S. holder (even though the individual is not considered a resident of the United States), provided the non-U.S. holder has timely
filed U.S. federal income tax returns with respect to such losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the third bullet point above, we believe we are not currently and do not anticipate becoming in the future a USRPHC. Because
the determination of whether we are a USRPHC depends on the fair market value of our USRPIs relative to the fair market value of our
other business assets and our non- U.S. real property interests, however, there can be no assurance we are not a USRPHC or will not become
one in the future. If we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our Common Stock
by a non-U.S. holder will not be subject to U.S. federal income tax if our Common Stock is &ldquo;regularly traded,&rdquo; as defined
by applicable Treasury Regulations, on an established securities market and such non-U.S. holder owned, actually and constructively,
5% or less of our Common Stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition
or the non-U.S. holder&rsquo;s holding period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Reporting and Backup Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. holder will not be subject to backup withholding with respect to distributions on Common Stock we make to the non-U.S. holder,
provided the applicable withholding agent does not have actual knowledge or reason to know such non-U.S. holder is a United States person
and such non-U.S. holder certifies its non-U.S. status, such as by providing a valid IRS Form W-8BEN, W-8BEN-E or other applicable certification.
Information returns generally will be filed with the IRS, however, in connection with any distributions (including deemed distributions)
made on Series Rights and Common Stock to the non-U.S. holder, regardless of whether any tax was actually withheld. In addition,
proceeds of the sale or other taxable disposition of our Common Stock within the United States or conducted through certain U.S.-related
brokers generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the
certification described above and does not have actual knowledge or reason to know that such holder is a United States person or the
holder otherwise establishes an exemption. Proceeds of a disposition of our Common Stock conducted through a non-U.S. office of a non-U.S.
broker generally will not be subject to backup withholding or information reporting. Copies of these information returns may also be
made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the non-U.S. holder
resides or is established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit
against a non-U.S. holder&rsquo;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Withholding Tax on Payments Made to Foreign Accounts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding
taxes may be imposed under the Foreign Account Tax Compliance Act (&ldquo;FATCA&rdquo;), on certain types of payments made to non-U.S.
financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends (including
deemed dividends) on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition
of, our Common Stock paid to a &ldquo;foreign financial institution&rdquo; or a &ldquo;non-financial foreign entity&rdquo; (each as defined
in the Code), unless (1) the foreign financial institution undertakes certain diligence and reporting obligations, (2) the non-financial
foreign entity either certifies it does not have any &ldquo;substantial United States owners&rdquo; (as defined in the Code) or furnishes
identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign
entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence
and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other
things, that it undertake to identify accounts held by certain &ldquo;specified United States persons&rdquo; or &ldquo;United States-owned
foreign entities&rdquo; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain
payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in
jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends (including
deemed dividends) on our Common Stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale
or other disposition of our rights or Common Stock on or after January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding
on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations
are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
should consult their tax advisors regarding the potential application of withholding under FATCA to their receipt, ownership, and exercise
of Unit Subscription Rights, Series A Rights and Series B Rights and the ownership and disposition of shares of
our Common Stock acquired upon exercise of Unit Subscription Rights, Series A Rights and Series B Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_011"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered hereby will be passed upon by Lewis Brisbois Bisgaard &amp; Smith, LLP, San Francisco, California.
Moody Capital is being represented in connection with this offering by Procopio, Cory, Hargreaves &amp; Savitch LLP, San Diego, California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_012"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements as of December 31, 2024 and December 31, 2023 have been included in the report of Sadler, Gibb &amp; Associates,
LLC, an independent registered public accounting firm, as stated in its report incorporated by reference herein, and have been so incorporated
in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_013"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the
public over the internet at the SEC&rsquo;s website at www.sec.gov. Copies of certain information filed by us with the SEC are also available
on our website at www.amplitechgroup.com. Our website is not a part of this prospectus supplement and is not incorporated by reference
into this prospectus supplement or the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement is only part of a registration statement we filed with the SEC and therefore omits some information contained in
our registration statement in accordance with the SEC&rsquo;s rules and regulations. You should review the information contained in any
exhibits filed to the registration statement for further information on us and the securities we are offering. Statements in this prospectus
supplement concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not
intended to be comprehensive and are qualified by reference to those filings. You should review the complete document to evaluate these
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="form424b5_004.jpg" ALT="" style="width:350px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferable
Unit Subscription Right to Purchase up to 8,000,000 Units,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit Consisting of One Share of Common Stock,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
Series A Right, and One Series B Right,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">up
to 8,000,000 Shares of Common Stock Upon Exercise of Unit Subscription Rights,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
up to 16,000,000 Shares of Common Stock Issuable Upon Exercise of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Series A Rights and Series B Rights,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">up
to a Total of 24,000,000 Shares of Common</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
in the Aggregate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealer-Manger</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form424b5_003.jpg" ALT="" STYLE="height: 64px; width: 159px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="form424b5_001.jpg" ALT="" STYLE="width: 300px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>AMPLITECH
GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>$200,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may offer and sell up to $200,000,000 in aggregate of the securities described in this prospectus separately or together
in any combination, in one or more classes or series, in amounts, at prices and on terms that we will determine at the time of the offering.
We may also offer common stock upon conversion of preferred stock, or common stock, or preferred stock upon the exercise of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus provides a general description of the securities we may offer. We may provide specific terms of securities to be offered in
one or more supplements to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a
prospectus supplement. Prospectus supplements may also add, update or change information in this prospectus. You should carefully read
this prospectus and the applicable prospectus supplement, together with any documents incorporated by reference herein, before you invest
in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock and warrants are listed on the Nasdaq Capital Market and trade under the symbols &ldquo;AMPG&rdquo; and &ldquo;AMPGW&rdquo;
respectively. The last reported sale price of our common stock on the Nasdaq Capital Market on July 18, 2025, was $2.86 per share. Each
prospectus supplement will indicate if the securities to be offered thereby will be listed on any securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus the aggregate market value of our outstanding common stock held by non-affiliates is approximately $51,516,230,
which is calculated based on 20,573,595 shares of outstanding common stock, of which 17,582,331 shares are held by non-affiliates, and
a per share price of $2.93, which was the closing price of our common stock on July 17, 2025, which is the highest closing sale price
of our common stock on Nasdaq Capital Market within the prior sixty (60) days of the filing of this Form S-3. Pursuant to General Instruction
I.B.6 of Form S-3, in no event will we sell securities pursuant to shelf registration statements, including the registration statement
of which this prospectus is a part, with a value more than one-third of the aggregate market value of our common stock held by non-affiliates
in any 12 month period, so long as the aggregate market value of our common stock held by non-affiliates is less than $75 million. In
the event that subsequent to the effective date of the registration statement of which this prospectus is a part, the aggregate market
value of our outstanding common stock held by non-affiliates equals or exceeds $75 million, then the one-third limitation on sales shall
not apply to additional sales made pursuant to the registration statement of which this prospectus is a part. We have sold an aggregate
of approximately $13,827,802 shares of common stock pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar months prior
to, and including, the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in any of our securities involves a high degree of risk. Please read carefully the section entitled &ldquo;Risk Factors&rdquo; on
page 6 of this prospectus, the &ldquo;Risk Factors&rdquo; section contained in the applicable prospectus supplement and the
information included and incorporated by reference in this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is August 4, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">INFORMATION WE INCORPORATE BY REFERENCE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">AMPLITECH GROUP, INC.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">DESCRIPTION OF WARRANTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">DESCRIPTION OF RIGHTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">DESCRIPTION OF UNITS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><A HREF="#a_015">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or the SEC, using
a &ldquo;shelf&rdquo; registration or continuous offering process. Under this shelf registration process, we may, from time to time,
sell any combination of the securities described in this prospectus in one or more offerings up to a total aggregate offering price of
$200,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus provides a general description of the securities we may offer. Each time we sell securities, we will, to the extent required,
provide a prospectus supplement containing specific information about the terms of that offering and the securities being offered. We
may provide specific terms of securities to be offered in one or more supplements to this prospectus. We may also provide a specific
plan of distribution for any securities to be offered in a prospectus supplement. Prospectus supplements may also add, update or change
information in this prospectus. If the information varies between this prospectus and the accompanying prospectus supplement, you should
rely on the information in the accompanying prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
purchasing any securities, you should carefully read both this prospectus and any prospectus supplement, together with the additional
information described under the heading &ldquo;Information We Incorporate by Reference.&rdquo; You should rely only on the information
contained or incorporated by reference in this prospectus, any prospectus supplement and any free writing prospectus prepared by or on
behalf of us or to which we have referred you. We have not authorized any other person to provide you with different information. If
anyone provides you with different or inconsistent information, you should not rely on it. We take no responsibility for and can provide
no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained
in this prospectus, any prospectus supplement or any free writing prospectus is accurate only as of the date on its respective cover,
and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless
we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates. This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &ldquo;Where
You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and any applicable prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities
other than the registered securities to which they relate. We may only offer to sell, and seek offers to buy, any securities in jurisdictions
where offers and sales are permitted. We are not making offers to sell common stock or any other securities described in this prospectus
in any jurisdiction in which an offer or solicitation is not authorized or in which we are not qualified to do so or to anyone to whom
it is unlawful to make an offer or solicitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly indicated or the context otherwise requires, we use the terms &ldquo;AmpliTech,&rdquo; the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; or similar references to refer to AmpliTech Group, Inc. together with any subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed our registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended, or the Securities Act. We
also file annual, quarterly and current reports, proxy statements and other information with the SEC. You can read and copy any document
that we file with the SEC, including the registration statement and the exhibits to the registration statement, over the internet at
the SEC&rsquo;s web site at www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information reporting requirements of the Exchange Act of 1934, as amended, or the Exchange Act, and we are required
to file reports, proxy statements and other information with the SEC. These reports, proxy statements, and other information are available
for inspection and copying at the SEC&rsquo;s website referred to above. These documents may also be accessed on our web site at www.amplitechinc.com.
Information contained on our website is not incorporated by reference into this prospectus and you should not consider information contained
on our website to be part of this prospectus. Information contained on or accessible through our website is not a part of this prospectus,
and the inclusion of our website address in this prospectus is an inactive textual reference only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and any prospectus supplement are part of a registration statement filed with the SEC and do not contain all of the information
in the registration statement. The full registration statement may be obtained from the SEC or us as indicated above. Other documents
establishing the terms of the offered securities are filed as exhibits to the registration statement or will be filed through an amendment
to our registration statement on Form S-3 or under cover of a Current Report on Form 8-K and incorporated into this prospectus by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>INFORMATION
WE INCORPORATED BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to &ldquo;incorporate by reference&rdquo; into this prospectus the information we file with it, which means that we can
disclose important information to you by referring you to those documents. The information incorporated by reference is considered to
be part of this prospectus. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference into
this document will be deemed to be modified or superseded for purposes of the document to the extent that a statement contained in this
document or any other subsequently filed document that is deemed to be incorporated by reference into this document modifies or supersedes
the statement. We incorporate by reference in this prospectus the following information (other than, in each case, documents or information
deemed to have been furnished and not filed in accordance with SEC rules):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001715/form10-k.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the fiscal year ended December 31, 2024 (filed with the SEC on March 31, 2025);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225010523/form10-q.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> filed with the SEC on May 15, 2025;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Current Reports on Form
    8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000149315225002942/form8-k.htm" STYLE="-sec-extract: exhibit">January 21, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225000178/form8-k.htm" STYLE="-sec-extract: exhibit">March 24, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001724/form8-k.htm" STYLE="-sec-extract: exhibit">March 31, 2025</A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225007751/form8-k.htm" STYLE="-sec-extract: exhibit">April 30, 2025</A>;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Form <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000147793221000843/ampg_8a12b.htm" STYLE="-sec-extract: exhibit">8-A12B</A>, filed with the SEC on February 16, 2021; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    description of the securities of the Company contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1518461/000164117225001715/ex4-4.htm" STYLE="-sec-extract: exhibit">Exhibit 4.4</A> of our Annual Report on Form 10-K for the year ended December
    31, 2024 (filed with the SEC on March 31, 2025).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference each of the documents that we file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934, as amended, or the Exchange Act, (i) after the date of this prospectus and prior to effectiveness of this registration
statement on Form S-3 and (ii) on or after the date of this prospectus and prior to the termination of the offerings under this prospectus
and any prospectus supplement. These documents include periodic reports, such as Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K, as well as proxy statements. We will not, however, incorporate by reference in this prospectus
any documents or portions thereof that are not deemed &ldquo;filed&rdquo; with the SEC, including any information furnished pursuant
to Item 2.02 or Item 7.01 of our Current Reports on Form 8-K after the date of this prospectus unless, and except to the extent, specified
in such Current Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide to each person, including any beneficial owner, to whom a prospectus (or a notice of registration in lieu thereof) is delivered
a copy of any of these filings (other than an exhibit to these filings, unless the exhibit is specifically incorporated by reference
as an exhibit to this prospectus) at no cost, upon a request to us by writing or telephoning us at the following address and telephone
number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">155
Plant Avenue, Hauppauge, NY 11788</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(631)
521-7831</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, including the documents incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo;
within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements discuss matters that are not historical
facts. Because they discuss future events or conditions, forward-looking statements may include words such as &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;would,&rdquo;
&ldquo;may,&rdquo; &ldquo;seek,&rdquo; &ldquo;plan,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;forecast,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; negatives thereof
or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions
and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results
of operations or plans expressed or implied by such forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict all the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results
or conditions described in such statements or that our objectives and plans will be achieved, and we do not assume any responsibility
for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places
throughout this prospectus, including the documents incorporated by reference herein, and include information concerning possible or
assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future
cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs,
future operations, business plans and future financial results, and any other statements that are not historical facts. All written and
oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the
cautionary statements disclosed under &ldquo;Risk Factors&rdquo; in this prospectus, as such risk factors may be amended, supplemented
or superseded from time to time by reports we file with the SEC, including subsequent Annual Reports on Form 10-K, Quarterly Reports
on Form 10-Q and Current Reports on Form 8-K, and in any prospectus supplement. Accordingly, forward-looking statements should be not
be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this
report and in our other filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business.
We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this
prospectus, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>AmpliTech
Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group Inc. (&ldquo;AMPG,&rdquo; &ldquo;AmpliTech&rdquo; or the &ldquo;Company&rdquo;), incorporated in 2010 in the state of Nevada, is
the parent company of AmpliTech, Inc., and the Company&rsquo;s divisions, Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech
Group MMIC Design Center (&ldquo;AGMDC&rdquo;) and AmpliTech Group True G Speed Services (&ldquo;AGTGSS&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech,
Inc. designs, engineers and assembles micro-wave component-based amplifiers that meet individual customer specifications. Our products
consist of Radio Frequency (&ldquo;RF&rdquo;) amplifiers and related subsystems, operating at multiple frequencies from 50kHz to 44GHz,
including low noise amplifiers (&ldquo;LNA&rdquo;), medium power amplifiers, cryogenic amplifiers, and custom assembly designs for the
global satellite communications, telecom (5G &amp; IoT), space, defense, and quantum computing markets. We also offer non-recurring engineering
services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time plus material basis. We have both
domestic and international customers in such industries as aerospace, governmental, defense and commercial satellite.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specialty
Microwave designs and manufactures state-of- the-art precision SATCOM microwave components, RF subsystems and specialized electronic
assemblies for the military and commercial markets, flexible and rugged waveguides, wave guide adapters and more.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2021, we acquired substantially all of the assets of Spectrum Semiconductor Materials Inc. (&ldquo;SSM&rdquo;), a globally
authorized distributor of integrated circuit (IC) packaging and lids for semiconductor device assembly, prototyping, testing, and production
requirements founded in 1990 and headquartered in San Jose, CA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, the Company opened AGMDC, a monolithic microwave integrated circuits (&ldquo;MMIC&rdquo;) chip design center, in Texas and has
started to implement several of its proprietary amplifier designs into MMIC components. MMICs are semiconductor chips used in high-frequency
communications applications. MMICs are widely desired for power amplification solutions to service emerging technologies, such as phased
array antennas and quantum computing. MMICs carry a smaller footprint enabling them to be incorporated into a broader array of systems
while reducing costs. AGMDC designs, develops and manufactures state-of-the-art signal processing components for satellite and 5G communications
networks, defense, space and other commercial applications, allowing the Company to market its products to wider base of customers requiring
high technology in smaller packages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, we formed our AGTGSS division to enable &ldquo;true G speeds&rdquo; to the industry. AGTGSS&rsquo; main function will be
to plan and configure 5G radio systems and make them O-RAN compliant. AGTGSS will implement AmpliTech&rsquo;s low noise amplifier devices
in these systems to promote greater coverage, longer range and faster speeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, we entered into an asset purchase agreement, as amended by that certain amendment dated April 15, 2025, with Titan Crest,
LLC, a Delaware limited liability company (&ldquo;Titan&rdquo;), and its affiliate, to purchase certain assets including intellectual
property used in developing, manufacturing, marketing and selling products that use radio frequency technology (&ldquo;5G ORAN radio
products).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to patent our proprietary IP and trade secrets that were used in small volume niche markets and expand our capabilities through
strategic partnerships, joint ventures, mergers/acquisitions with key industry leaders in the 5G/6G, quantum computing, and cybersecurity
markets. We believe this will enable us to scale up our products and revenue by developing full systems and subsystems with our unique
technology as a core component, which we expect will position us as a global leader in these rapidly emerging technology sectors and
addresses large volume markets as well, such as cellphone handsets, laptops, server networks, and many other applications that improve
everyday quality of life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s research and development initiative to expand its product line of low noise amplifiers to include its new 5G and wireless
infrastructure products, cryogenic amplifiers and MMIC designs is progressing significantly. Our combined engineering and manufacturing
resources are expected to complement the development of new subsystems for satellite, wireless, and 5G infrastructures, as well as advanced
military and commercial markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Corporate History and Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
Group Inc. was incorporated under the laws of the State of Nevada on December 30, 2010. On August 13, 2012, the Company acquired AmpliTech
Inc., by issuing 833,750 shares of the Company&rsquo;s common stock to the stockholders of AmpliTech Inc. in exchange for 100%
of the outstanding shares of AmpliTech Inc. (the &ldquo;Share Exchange&rdquo;). After the Share Exchange, the selling stockholders
owned 60,000 shares of the outstanding 893,750 shares of Company common stock, resulting in a change in control. Accordingly, the transaction
was accounted for as a reverse acquisition in which AmpliTech, Inc. was deemed to be the accounting acquirer, and the operations of the
Company were consolidated for accounting purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmpliTech
designs, engineers and assembles microwave component based low noise amplifiers (&ldquo;LNA&rdquo;) that meet individual customer specifications.
Application of the Company&rsquo;s proprietary technology results in maximum frequency gain with minimal background noise distortion
as required by each customer. The Company has both domestic and international customers in such industries as aerospace, governmental,
defense and commercial satellite.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 12, 2019, AmpliTech Group Inc. acquired substantially all of the assets of Specialty Microwave Corporation, a privately held
company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and goodwill. Following
the closing of the asset purchase, we hired all eight team members of SMW. In connection with the acquisition, the Company began using
the trade name &ldquo;Specialty Microwave&rdquo;. Specialty designs and manufactures passive microwave components and related subsystems
that meet individual customer specifications for both domestic and international customers for use in satellite communication ground
networks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2021, AmpliTech Group Inc.&rsquo;s common stock and warrants commenced trading on NASDAQ under the symbols &ldquo;AMPG&rdquo;
and &ldquo;AMPGW,&rdquo; respectively. A reverse split of the outstanding common stock at a 1-for-20 ratio became effective February
17, 2021, as of 12:01 a.m., Eastern Time. All share amounts have been retroactively re-stated to reflect the reverse split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2021, AmpliTech Group, Inc. entered into an Asset Purchase Agreement with SSM, pursuant to which AmpliTech would acquire
substantially all of the assets of SSM. SSM, located in Silicon Valley (San Jose, CA), was a global authorized distributor of IC packaging
and lids for semiconductor device assembly, prototyping, testing, and production requirements. The acquisition was completed on December
15, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, the Company opened a MMIC chip design center in Texas and has started to implement several of its proprietary amplifier designs
into MMIC components. MMICs are semiconductor chips used in high-frequency communications applications. MMICs are widely desired for
power amplification solutions to service emerging technologies, such as phased array antennas and quantum computing. MMICs carry a smaller
footprint enabling them to be incorporated into a broader array of systems while reducing costs. AGMDC designs, develops and manufactures
state-of-the-art signal processing components for satellite and 5G communications networks, defense, space and other commercial applications,
allowing the Company to market its products to a wider base of customers requiring high technology in smaller packages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, our AGTGSS division was founded to serve and provide complete system integration and ORAN compliant O-RU&rsquo;s (Radio
Units) for telcos, enabling the industry to access &lsquo;True 5G Speeds&rsquo;. AGTGSS provides Managed Services, Cyber Security, Cloud
Services, Data Sciences and Telco Cloud Services. AGTGSS will also be providing full installation of Private 5G Networks (P5G), which
includes the deployment of AmpliTech Group developed radio units. AGTGSS will implement AmpliTech&rsquo;s low noise amplifier devices
in these systems to promote greater coverage, longer range and faster speeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, we entered into an asset purchase agreement, as amended by that certain amendment dated April 15, 2025, with Titan, and
its affiliate, to purchase certain assets including intellectual property used in developing, manufacturing, marketing and selling products
that use radio frequency technology (&ldquo;5G ORAN radio products). The aggregate purchase price for the assets is $8,000,000, which
consists of $4,000,000 in cash and $4,000,000 in restricted shares of common stock of which the first $3,500,000 in cash was paid and
$1,500,000 in restricted common stock was issued on April 24, 2025. The remaining $500,000 in cash to be paid and $2,500,000 in shares
of restricted common stock will be issued to Titan upon the transfer of the 5G ORAN radio products&rsquo; technology and intellectual
property rights by Titan to the Company. The second milestone is expected to be achieved towards the end of the year 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being a Smaller Reporting Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company&rdquo; meaning that the market value of our common stock held by non-affiliates is less than $250.0
million measured on the last business day of our most recent second fiscal quarter or our annual revenue is less than $100.0 million
during the most recent completed fiscal year and the market value of our common stock held by non-affiliates is less than $700.0 million
measured on the last business day of our most recent second fiscal quarter. Accordingly, we may provide less public disclosure than larger
public companies, including the inclusion of only two years of audited financial statements and only two years of management&rsquo;s
discussion and analysis of financial condition and results of operations disclosure. As a result, the information that we provide to
our stockholders may be different than what you might receive from other public reporting companies in which you hold equity interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider any risk factors
set forth in the applicable prospectus supplement and in the documents incorporated by reference in this prospectus. See &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Information We Incorporate By Reference.&rdquo; Each of the risks described in these
documents could materially and adversely affect our business, financial condition, results of operations and prospects, and could result
in a partial or complete loss of your investment. Additional risks and uncertainties not presently known to us, or that we currently
deem immaterial, may also adversely affect our business. In addition, past financial performance may not be a reliable indicator of future
performance and historical trends should not be used to anticipate results or trends in future periods. This prospectus and the documents
incorporated herein by reference also contain forward-looking statements that involve risks and uncertainties. Actual results could differ
materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described in
the documents incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will retain broad discretion over the use of the net proceeds from the sale of the securities offered hereby. Unless otherwise specified
in any prospectus supplement, we currently intend to use the net proceeds from the sale of our securities offered under this prospectus
for working capital and general corporate purposes including, but not limited to, research and development; engineering, operations,
quality inspection, information technology and sales force expansion; marketing and sales and working capital. Pending any specific application,
we may initially invest funds in short-term marketable securities or apply them to the reduction of indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information describes the common stock, par value $0.001 per share, and blank check preferred stock, par value $0.001 per share,
as well as certain provisions of our amended and restated articles of incorporation, as amended (&ldquo;Articles of Incorporation&rdquo;)
and our amended and restated bylaws (&ldquo;Bylaws&rdquo;). This description is only a summary. You should also refer to our Articles
of Incorporation and Bylaws, which have been filed with the SEC as exhibits to the registration statement of which this prospectus forms
a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
and Outstanding Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 500,000,000 shares of common stock, $0.001 par value per share, and 1,000,000 shares of blank check
preferred stock, $0.001 par value per share. As of July 22, 2025, there are 20,573,595 shares of common stock and no shares of preferred
stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, and
do not have cumulative voting rights. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders
of common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors
out of funds legally available for dividend payments. All outstanding shares of common stock are fully paid and non-assessable, and the
shares of common stock to be issued upon completion of this offering will be fully paid and non-assessable. The holders of common stock
have no preferences or rights of cumulative voting, conversion, or pre-emptive or other subscription rights. There is no redemption or
sinking fund provisions applicable to the common stock. In the event of any liquidation, dissolution or winding up of our affairs, holders
of common stock will be entitled to share ratably in any of our assets remaining after payment or provision for payment of all of our
debts and obligations and after liquidation payments to holders of outstanding shares of preferred stock, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board generally will be authorized, without further stockholder approval, to issue from time to time up to an aggregate of 1,000,000
shares of preferred stock, in one or more series. Each series of preferred stock will have the number of shares, designations, preferences,
voting powers (or special, preferential or no voting powers), relative, participating, optional or other special rights and privileges
and such qualifications, limitations or restrictions as is determined by the Board, which may include, among others, the right to provide
that the shares of each such series may be: (i) subject to redemption at such time or times and at such price or prices; (ii) entitled
to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions, and at such times, and payable in
preference to, or in such relation to, the dividends payable on any other class or classes or any other series; (iii) entitled to such
rights upon the dissolution of, or upon any distribution of the assets of, the Company; (iv) convertible into, or exchangeable for, shares
of any other class or classes of stock, or of any other series of the same or any other class or classes of stock of the Company at such
price or prices or at such rates of exchange and with such adjustments, if any; or (v) entitled to the benefit of such limitations, if
any, on the issuance of additional shares of such series or shares of any other series of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stockholders have granted the Board authority to issue the preferred stock and to determine the rights and preferences of the preferred
stock in order to eliminate delays associated with a stockholder vote on specific issuances. The rights of the holders of common stock
will be subordinate to the rights of holders of any preferred stock issued in the future. The issuance of preferred stock, while providing
desirable flexibility in connection with possible acquisitions and other corporate purposes, could adversely affect the voting power
or other rights of the holders of common stock, and could make it more difficult for a third party to acquire, or discourage a third
party from attempting to acquire, a majority of our outstanding voting stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will fix the designations, voting powers, preferences and rights of the preferred stock of each series we issue under this prospectus,
as well as the qualifications, limitations or restrictions thereof, in the certificate of designation relating to that series. We will
file as an exhibit to the registration statement of which this prospectus is a part or will incorporate by reference from reports that
we file with the SEC, the form of any certificate of designation that contains the terms of the series of preferred stock we are offering.
We will describe in the applicable prospectus supplement the terms of the series of preferred stock being offered, including, to the
extent applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title and stated value;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares we are offering;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    liquidation preference per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate, period and payment date and method of calculation for dividends;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    procedures for any auction and remarketing, if applicable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for a sinking fund, if applicable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase
    rights;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    listing of the preferred stock on any securities exchange or market;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, or how it will be calculated,
    and the conversion period;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or how it will be calculated,
    and the exchange period;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
    rights of the preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemptive
    rights, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on transfer, sale or other assignment;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    interests in the preferred stock will be represented by depositary shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    discussion of material United States federal income tax considerations applicable to the preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our
    affairs;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred
    stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects of Some Provisions of Nevada Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following provisions of the Nevada Revised Statutes (&ldquo;NRS&rdquo;) could, if applicable, have the effect of discouraging takeovers
of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transactions
with Interested Stockholders. </I>The NRS prohibits a publicly traded Nevada company from engaging in any business combination with an
interested stockholder for a period of three years following the date that the stockholder became an interested stockholder unless, prior
to that date, the Board of Directors of the corporation approved either the business combination itself or the transaction that resulted
in the stockholder becoming an interested stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
&ldquo;interested stockholder&rdquo; is defined as any entity or person beneficially owning, directly or indirectly, 10% or more of the
outstanding voting stock of the corporation and any entity or person affiliated with, controlling, or controlled by any of these entities
or persons. The definition of &ldquo;business combination&rdquo; is sufficiently broad to cover virtually any type of transaction that
would allow a potential acquirer to use the corporation&rsquo;s assets to finance the acquisition or otherwise benefit its own interests
rather than the interests of the corporation and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, business combinations that are not approved and therefore take place after the three year waiting period may also be prohibited
unless approved by the board of directors and stockholders or the price to be paid by the interested stockholder is equal to the highest
of (i) the highest price per share paid by the interested stockholder within the 3 years immediately preceding the date of the announcement
of the business combination or in the transaction in which he or she became an interested stockholder, whichever is higher; (ii) the
market value per common share on the date of announcement of the business combination or the date the interested stockholder acquired
the shares, whichever is higher; or (iii) if higher for the holders of preferred stock, the highest liquidation value of the preferred
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acquisition
of a Controlling Interest. </I>The NRS contains provisions governing the acquisition of a &ldquo;controlling interest&rdquo; and provides
generally that any person that acquires 20% or more of the outstanding voting shares of an &ldquo;issuing corporation,&rdquo; defined
as Nevada corporation that has 200 or more stockholders at least 100 of whom are Nevada residents (as set forth in the corporation&rsquo;s
stock ledger); and does business in Nevada directly or through an affiliated corporation, may be denied voting rights with respect to
the acquired shares, unless a majority of the disinterested stockholder of the corporation elects to restore such voting rights in whole
or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statute focuses on the acquisition of a &ldquo;controlling interest&rdquo; defined as the ownership of outstanding shares sufficient,
but for the control share law, to enable the acquiring person, directly or indirectly and individually or in association with others,
to exercise (i) one-fifth or more, but less than one-third; (ii) one-third or more, but less than a majority; or (iii) a majority or
more of the voting power of the corporation in the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
question of whether or not to confer voting rights may only be considered once by the stockholders and once a decision is made, it cannot
be revisited. In addition, unless a corporation&rsquo;s articles of incorporation or bylaws provide otherwise (i) acquired voting securities
are redeemable in whole or in part by the issuing corporation at the average price paid for the securities within 30 days if the acquiring
person has not given a timely information statement to the issuing corporation or if the stockholders vote not to grant voting rights
to the acquiring person&rsquo;s securities; and (ii) if voting rights are granted to the acquiring person, then any stockholder who voted
against the grant of voting rights may demand purchase from the issuing corporation, at fair value, of all or any portion of their securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of this section do not apply to acquisitions made pursuant to the laws of descent and distribution, the enforcement of a judgment,
or the satisfaction of a security interest, or acquisitions made in connection with certain mergers or reorganizations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock and Public Warrants are traded on Nasdaq under the symbol &ldquo;AMPG&rdquo; and &ldquo;AMPGW&rdquo;, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock and Public Warrants is VStock Transfer LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a general description of the terms of the warrants we may issue from time to time. Particular terms of any warrants we offer
will be described in the prospectus supplement relating to such warrants, as well as any warrant agreement that contains the terms of
the warrants. We urge you to read the applicable prospectus supplements related to the warrants that we may sell under this prospectus,
as well as the complete warrant agreements that will contain the terms of any warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue warrants to purchase shares of our common stock or preferred stock. Such warrants may be issued in one or more series, independently
or together with shares of common stock or preferred stock or other equity or debt securities and may be attached or separate from such
securities. The warrants may also be in the form of pre-funded warrants. The terms of any warrants offered under a prospectus supplement
may differ from the terms described below. We may issue warrants directly or under a separate warrant agreement to be entered into between
us and a warrant agent. We will name any warrant agent in the applicable prospectus supplement. Any warrant agent will act solely as
our agent in connection with the warrants of a particular series and will not assume any obligation or relationship of agency or trust
for or with holders or beneficial owners of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable prospectus supplement and the applicable warrant agreement will describe the particular terms of any series of warrants we
may issue, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title of such warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    aggregate number of such warrants offered;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            price or prices at which such warrants will be issued;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the designation and terms of the securities with which the warrants are issued
                                            and the number of warrants issued with each such security or each principal amount of such
                                            security;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of warrants to purchase debt securities, the principal amount of debt securities
                                            purchasable upon exercise of one warrant and the price at, and currency in which, this principal
                                            amount of debt securities may be purchased upon such exercise;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of warrants to purchase common stock or preferred stock, the number of shares of
                                            common stock or preferred stock, as the case may be, purchasable upon the exercise of one
                                            warrant and the price at which these shares may be purchased upon such exercise;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which the right to exercise such warrants shall commence and the date on which such
                                            right will expire;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            such warrants will be issued in registered form or bearer form;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the minimum or maximum amount of such warrants which may be exercised at any
                                            one time;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    applicable, the date on and after which such warrants and the related securities will be separately transferable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    with respect to book-entry procedures, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the securities issuable upon exercise of the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    anti-dilution provisions of the warrants, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    redemption or call provisions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    applicable, a discussion of certain federal United States income tax considerations; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and the warrant agent, if any, may amend or supplement the warrant agreement for a series of warrants without the consent of the holders
of the warrants issued thereunder to effect changes that are not inconsistent with the provisions of the warrants and that do not materially
and adversely affect the interests of the holders of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such
exercise, including the right to receive distributions or dividends, if any, or payments upon our liquidation, dissolution or winding
up or to exercise any voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_010"></A>DESCRIPTION
OF RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description, together with the additional information we include in any applicable prospectus supplement, summarizes the general
features of the rights that we may offer under this prospectus. We may issue rights to our stockholders to purchase shares of our common
stock and/or any of the other securities offered hereby. Each series of rights will be issued under a separate rights agreement to be
entered into between us and a bank or trust company, as rights agent. When we issue rights, we will provide the specific terms of the
rights and the applicable rights agreement in a prospectus supplement. Because the terms of any rights we offer under a prospectus supplement
may differ from the terms we describe below, you should rely solely on information in the applicable prospectus supplement if that summary
is different from the summary in this prospectus. We will incorporate by reference into the registration statement of which this prospectus
is a part the form of rights agreement that describes the terms of the series of rights we are offering before the issuance of the related
series of rights. The applicable prospectus supplement relating to any rights will describe the terms of the offered rights, including,
where applicable, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date for determining the persons entitled to participate in the rights distribution;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise price for the rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    aggregate number or amount of underlying securities purchasable upon exercise of the rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of rights issued to each stockholder and the number of rights outstanding, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    extent to which the rights are transferable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    conditions to completing the Rights Offering;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which the right to exercise the rights will commence and the date on which the right will expire;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    extent to which the rights include an over-subscription privilege with respect to unsubscribed securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">anti-dilution
    provisions of the rights, if any; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the
    rights.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
may exercise rights as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly
completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement,
we will, as soon as practicable, forward the securities purchasable upon exercise of the rights. If less than all of the rights issued
in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through
agents, underwriters or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as
described in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>DESCRIPTION
OF UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue units comprising two or more securities described in this prospectus in any combination. For example, we might issue units
consisting of a combination of common stock, preferred stock, warrants to purchase common stock or any combination of such securities.
The following description sets forth certain general terms and provisions of the units that we may offer pursuant to this prospectus.
The particular terms of the units and the extent, if any, to which the general terms and provisions may apply to the units offered will
be described in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
unit will be issued so that the holder of the unit also is the holder of each security included in the unit. Thus, the unit will have
the rights and obligations of a holder of each included security. Units will be issued pursuant to the terms of an agreement, which may
provide that the securities included in the unit may not be held or transferred separately at any time or at any time before a specified
date. A copy of the forms of such agreement and the unit certificate, if applicable, relating to any particular issue of units will be
filed with the SEC each time we issue units, and you should read those documents for provisions that may be important to you. For more
information on how you can obtain copies of the forms of the unit agreement and the related unit certificate, see &ldquo;Where You Can
Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prospectus supplement relating to any particular issuance of units will describe the terms of those units, including, to the extent applicable,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    designation and terms of the units and the securities comprising the units, including whether and under what circumstances those
    securities may be held or transferred separately;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    provision for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the units will be issued in fully registered or global form.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_012"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the securities from time to time, by a variety of methods, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    any national securities exchange or quotation service on which our securities may be listed at the time of sale, including Nasdaq;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the over-the-counter market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions otherwise than on such exchange or in the over-the-counter market, which may include privately negotiated transactions
    and sales directly to one or more purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    underwriters, broker-dealers, agents, in privately negotiated transactions, or any combination of these methods;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    short sales;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any of these methods; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may be distributed from time to time in one or more transactions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a fixed price or prices, which may be changed;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    market prices prevailing at the time of sale;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    prices related to such prevailing market prices; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    negotiated prices.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe
the terms of the offering of the securities, including, to the extent applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    name or names of the underwriters, dealers or agents, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price of the securities or other consideration therefor, and the proceeds, if any, we will receive from the sale;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    over-allotment or other options under which underwriters may purchase additional securities from us;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    agency fees or underwriting discounts and other items constituting agents&rsquo; or underwriters&rsquo; compensation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    public offering price;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    discounts or concessions allowed or reallowed or paid to dealers; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    securities exchange or market on which the securities may be listed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offers
to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers
to purchase the securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus
supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a dealer is utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal.
The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed
with the underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter
will use to make resales of the securities to the public. In connection with the sale of the securities, we, or the purchasers of securities
for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter
may sell the securities to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions
from the underwriters and/or commissions from the purchasers for which they may act as agent. Unless otherwise indicated in a prospectus
supplement, an agent will be acting on a best-efforts basis and a dealer will purchase securities as a principal and may then resell
the securities at varying prices to be determined by the dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions
or commissions allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters,
dealers and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities
Act, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to
be underwriting discounts and commissions. In compliance with the guidelines of the Financial Industry Regulatory Authority, Inc., or
FINRA, the maximum amount of underwriting compensation, including underwriting discounts and commissions, to be paid in connection with
any offering of securities pursuant to this prospectus may not exceed 8% of the aggregate principal amount of securities offered. We
may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities
Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses.
The securities may or may not be listed on a national securities exchange. To facilitate the offering of securities, certain persons
participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This
may include over-allotments or short sales of the securities, which involve the sale by persons participating in the offering of more
securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making
purchases in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain
the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions
allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization
transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that
which might otherwise prevail in the open market. These transactions may be discontinued at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
indicated in the applicable prospectus supplement, underwriters or other persons acting as agents may be authorized to solicit offers
by institutions or other suitable purchasers to purchase the securities at the public offering price set forth in the prospectus supplement,
pursuant to delayed delivery contracts providing for payment and delivery on the date or dates stated in the prospectus supplement. These
purchasers may include, among others, commercial and savings banks, insurance companies, pension funds, investment companies and educational
and charitable institutions. Delayed delivery contracts will be subject to the condition that the purchase of the securities covered
by the delayed delivery contracts will not at the time of delivery be prohibited under the laws of any jurisdiction in the United States
to which the purchaser is subject. The underwriters and agents will not have any responsibility with respect to the validity or performance
of these contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may engage in at-the-market offerings into an existing trading market in accordance with rule 415(a)(4) under the Securities Act. In
addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties
in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third
parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions.
If so, the third party may use securities pledged by us, or borrowed from us or others to settle those sales or to close out any related
open borrowings of common stock and may use securities received from us in settlement of those derivatives to close out any related open
borrowings of our common stock. In addition, we may loan or pledge securities to a financial institution or other third party that in
turn may sell the securities using this prospectus and an applicable prospectus supplement. Such financial institution or other third
party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters, dealers and agents may engage in transactions with us, or provide services for us, in the ordinary course of business for
which they receive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_013"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in the applicable prospectus supplement, certain legal matters in connection with the offering and the validity of
the securities offered by this prospectus, and any supplement thereto, will be passed upon by Lewis Brisbois Bisgaard &amp; Smith LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_014"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements as of December 31, 2024 and December 31, 2023 have been included in the report of Sadler, Gibb &amp; Associates,
LLC, an independent registered public accounting firm, as stated in its report incorporated by reference herein, and have been so incorporated
in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_015"></A>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
SECURITIES ACT LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada
law provides that a Nevada corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, other than an action by or
in the right of the corporation (i.e., a &ldquo;non-derivative proceeding&rdquo;), by reason of the fact that he or she is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys&rsquo;
fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or
proceeding if he or she:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
    not liable under Section 78.138 of the Nevada Revised Statutes for breach of his or her fiduciary duties to the corporation; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acted
    in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a Nevada corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor (i.e., a &ldquo;derivative
proceeding&rdquo;), by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation, or is or
was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise against expenses, including amounts paid in settlement and attorneys&rsquo; fees actually and reasonably incurred
by him or her in connection with the defense or settlement of the action or suit if he:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
    not liable under Section 78.138 of the Nevada Revised Statute for breach of his or her fiduciary duties to the corporation; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acted
    in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nevada law, indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of
competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement
to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent
jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled
to indemnity for such expenses as the court deems proper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of
any non-derivative proceeding or any derivative proceeding, or in defense of any claim, issue or matter therein, the corporation is obligated
to indemnify him or her against expenses, including attorneys&rsquo; fees, actually and reasonably incurred in connection with the defense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Nevada law permits a Nevada corporation to purchase and maintain insurance or to make other financial arrangements on behalf of any person
who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise for any liability
asserted against him or her and liability and expenses incurred by him or her in his or her capacity as a director, officer, employee
or agent, or arising out of his or her status as such, whether or not the corporation has the authority to indemnify him or her against
such liability and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the Company pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC this indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b5_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b5_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# <(# 2(  A$! Q$!_\0
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M\&?@C'H@^*WC[P_X*_X2*6YAT5]?O+:RBU*:R'^E"U+'YB.?O''/7/)\;?\
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M*&#Q>59;F:S1-?%-OFC:'6.F]G=ZZG]-S?M/?LV'C_AH'X(8SD9^)_@L'O\
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M?MS>(_!/BSQ]\=_V<?#GB3PC;:C8'4/#YM8IM7M[P#_1;O??_*-//15P,Y.
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MSYAOK4$8YY_T[ X(QGOBOV MOV>(X_\ @CYX9_9)3XJ>&GU[3+G5KF7XF?9
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M?*,U?]J93EN5IY4\MS2+5UI]I.S[;/<_E!M_M/V6V_T_4/\ CUM^/M7M^7H
M?_UU^UG_  2)_P""B/P2_87T_P",.F_&A?'-X/'5YH]YH7_",Z2=>_X\U877
MVH!D%B0Q!YR,9& 2"/Q3M9$^RVW\!^RV_KQZ_P">O;(Q7[(?\$LO^"=7PI_;
M[\(?%[_A/O$WBCP;J_@35='ATC6?"YM1<26UXK&ZMKL7H.1N !Z8SGG&#\OP
MO4S1YS; ?[VT_P#D:.W1_CK][/Z\^EKD_A!3\$,R_P"(JX;-<%PG_:N5?VIF
MG"N5Y9_:NKRK:W3OTM>^ES _X*X_MV?"?]N;QY\)_$/P;/C*TT?P1X>U'2]7
M_P"$BTXZ1.)KRY6[ M;-F8L0!RP(W>@&17Y"ZE</;Z;>337^H>3;VMQ++_I7
MM^/K7]<T?_!M[\!Y%WGX]_%:)@.?+.F;1GC[Q5?3T/J1@UYE^RG_ ,$KO^"7
M_BC]J/XA?"'2?VAO$_[0OQ8_9P_L_6OBG\(-1C*^'?#4U]=#^R3K%S:Z<EA=
MO]M/":?J1.["GN:^FQ?#'$6=8MXK'2C@[6NHM.W961_*?A]],GZ'?@KX<87@
MC@C"\5<3X/)KRRMYMPMEG]J9GFCO)N6:O1;O?9670\U^-.@ZUX _X(#_  _M
M/%MQ=Z1J'B;QKX.US3+6\E\FXDT_6KPWVDY'4;AM(!Y(&?>OYO(Y+Q8T1[_4
M/H+KG^6/P/4XYR:_T"OVY/\ @GOX5_;6^&?@CX/ZQX[\2?#7P#X*O+>]70_!
MPM+2WU 62A-)MW+;MJZ<J# 53TSQR:_(_P"*G_!!']DWX*_#OQ5\6?B9^TS\
M4O#O@3P5I9UGQ3KDR6D]O8:<+G[)D@A6(^VWEH.!]XKVR1U<0<-YQF%;"U,*
MTL+@\K>6)<RYG9+F=E9V\WNEUMI^7_19^E]X%^&7#G&__$1UFW^L/&G'V9\4
MO+<JRC+\SAE>65'[B4I))RLES13]U]$K(YC_ (-]+P1_"']K6WFU!Q-'!J\O
M^DW2W'E6_P!EO>!N/<]"OS>AY-?S>?$J:>3XJ?%1X=0U!TD^(/BC]Y]JNN?]
M*XK^N+]GW]BO]FC_ ()\? /XK?M(W/[27Q&T7X/_ !E^&EKH^HS^+;:U_P")
M=;>(C]B\/7WAVSL@+_\ X2K7VO+1=)Y/_'XN<;@1\]?";_@@=^SE\:O!EA\1
M]#^-7Q[TO3O$LES=PV?BF"ST_6YCN %S=VC6/5NW3.&%7F/#>9XO)<DP--I8
MO IMMV22TUOV2W;M8?A5]*WZ/W"'CIX\>(6<XG-'PYX@?V4N%N7A?+I2]U-3
MO"UHV=N7D7O)J4M7$_%+_@F=<O'_ ,% /V6Y)M2N(?\ BX%O'^\NO2UO.WX?
M7I[5_H@-O$LH$S'>0V%P1P,< Y&>2??/X5_/3\.?^#?#X4?#+XB>#/B7X5_:
M)^+%AXE\!Z];^(M"N$_LW,-S: <%2N,8/)SC'Z?T)6]I+:PQ([B1DM88I;J7
M \R<#!GXZD\\#T'!KZ'A;+,5E.7_ %7'-/%/JFFGVU]5TOV/Y;^FSXO^'/C;
MXFY9Q?X88B3RF/"^5Y5F2S/*GE<E++?=NE?6Z=K]D[6Z_AI_P<8/*_\ P3!^
M(02X>&3_ (6)\.%\V-_(:;_2[P\-UP>Z]N#@9K_/9\Z_VPC[9J*9B@S_ *5W
M[>_MV./J:_T\_P#@I!^Q)\)OVZ/@-'\*_CA\7/%'PB^&^D>(].\5:KK7A_6]
M)\.PWESI#-]C35M4UL?V?Y:X)7)/5@JFOYL;3_@D!_P1[GD^(MM;_MJ?'XO\
M*_!U_P"//%UO?6-W8"'P=9ZJ-'O->TB[O/">GZ?K5B+W[+8"_P!.&IY.%. <
MC^H_![Q,X-X'R;$X#B/#?7L7CLTYE;+.9).R27W7^;/\P_$_P_XLXLSG#8_(
M<3]3PN!RNS_X4G'U?S>EUOO?MT?_  :NWDS^./VK;6XO+BX;_A&O#LI@N)?.
MP/[5ZC(_#W)/8U^??_!QKIVMV/\ P5)\4:S,^H66FZW\%OA?::/.)[B*"Z:R
MTR]%ZMJ4RI96!5L8 8,.*_J'_P""6G_!*WX _L77VI?M#_ #XM_&GQ/H?QO\
M"Z=#<^'/B1/I8TJ?2/M'VVSU2YM+.R'V._+8O1SSDYRNX#I_C7^R[^PM_P %
MH_A_KFNZG8W^IWWPD^('CGX.:+\7M!C.C^*?#OC#P=>+9^+M,TI[M7^V6.GW
MYZ:BA+,00.2:\?#^(O#>#\6\5QQ2RYOA[%_96Z3BDW;?7E;6NS>ECT,1P'Q%
MB/#3#<+_ %E+-L&^^E];+5]-M?/6Y_G+Z;=RZ=KWAO5+^2_O;/1_$?A_5+^S
M^U?\?FGV>J65Y=VIS_TX_AT&:_MS\+_\%:O^"(=UX9T";5_@[X?M-2.D6,5[
M9WGP4T!;BWGM+86=PMV>0Q3D9().>1Q7C_Q\_P"#=[_@G=^R]\'_ !G\=OC3
M^TS^T+X>^&WP\L+'4/%&N-?Z%<RP6MUJ=EH]H6MO[-Q>$ZA>V8"8)QEAPIQZ
M%IO_  ;"_L0:UX>T[QBGQ[_:!LM%U/0[3Q-#>:EJ'ABR>TTB]M5O+2ZN[DZ>
M%L@+(@LV_:%#,V-IKZ_CCQ!\)..7A:N*7%6">"O;^S%EL5JM;K1.R6G,G9[6
M;/E^$^#/%3A/ZS2PCRG&K&[O,FI:KTOKKM?7;L=W_P /8_\ @AFIQ_PJ3PMQ
MV'P4T']26)_D>E?3G[#?[=W_  3@_:D_:8U?X4?LE? ^#1O'GAKX<WWC.Z^(
M]M\+=)\*:19:>+I=';3+35[(%OMS&[[$#!V@9P:_)SX=_P#!#C_@D]\5_BG-
M\%_ 7[7WQP\0_$2*WU>ZMM'6V^PV^N:;X<.-5O/#VL7OA[3] \3V&G9&Z_\
M#VHZFB_,6;"Y/[7_ /!/7_@C/\!/^"<_Q#\9?$KX5?$#XE^,]?\ &GAX>'+B
M/QQ>:7<6.GV NA>C[)]CL4P=PVX.0<#)P<#\QSNKX7O*\5_8^)XHQF;?\RS^
MT[?V9;T:;6SZ=#]&R:EXBSQ^&_MG+N&,'E+U?]F:M>EV_EHO0_@__P""AWA/
MQ1\._P!O3]K+PAXHFU*SUW3_ (MZO=PG[5="WU*WO-M[:76E9P;RQ]OS&>C?
MV _VD='_ &4?VQ/@M\?O'D.LZKX-\'ZI]E\11Z5+Y^JPZ/>?\?=U:6G'VW'Z
M]>U?W[_MS_\ !(;]D?\ ;[ND\5_%3PU>>&OBM#80:9:?%?P5-_9WBH:>N +6
M[X-A>KSC)7(SG."!7YF-_P &L'['3$K_ ,+\_:&&(\9_M3P_P/7)T_.<8X[^
M_2OUO)O&K@'$\&87AW/LFS+!XJ65?V9F<LKRZ*33ZQ][9]+-V[GYCFOA1QMA
M^*,1G&19DL9A/[3_ +37]IYFVVUK[WG_ 'G965K;'U*?^#BG_@F_LC8^,/'6
M7&\(?"O/X_Z?_+K^=;'@O_@O=^Q3\5OB?\-_@Q\(H?B1XY\??%/Q -#\.6<?
MA9;?2K-@=UY=ZM=B^'V*RL+0;F/<\>IKX^7_ (-6?V.!S_PO;X_Y//\ Q^:
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M*3OKU:DGY*T=5%,^^\1>$^(.)N',MRS)W&&+P;3;;C%722U;:OMH[['\D/\
MP31U%-)_X*-_L2ZSK&LW%A867QNT^6ZU"\NOW,-O_9=[@W?'KCZ\>M?U*?\
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M6I:@,_9+2ZU4@"RYQDY/?@$Y'[ >(O!OA3Q1#]E\4^%?#GB6 =(]>T'2]5@
MSQ@7H.!UR,8Z\<4GAWP5X.\)Q/!X3\)>%_"T,A/F1Z#H6FZ(LQ_VELK,!NV
M<X]JZ_K?#M.E^\RW-/K3_P"IJN7[N1RM\[[>AS_4\]_A?VEEFV_]E_I>U_F?
M@L_AS_@J9_P4L:+1_B%IW_#O']DG6(;6YU72_#^O6>M_M#_$'3&=O/TDZM8;
M;[P2M_9,PU/.&<!OF=@V?V3_ &;OV:/@[^RE\+]&^$'P6\*6_A;PAHX$MT#&
MLVK:_J[A?MFN^(-5V!M9US42F_5=1D#,6RORJ J_0 ^[DKOYZCI]/3\L&K (
M(ZYQU/\ 7FN3$9G4Q=%X:GAU@L'=O^S(Z+;=MM\SMU;]%U.O!Y92H55B:O\
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MJ4MK-M* WW2ZAO!,BC,; $XP:_H36(, 9/+8CH0,?Y]OSP.*\D^->E?%/5O
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MO;#4="TL7ZWXP%RPZ$8\9_;!_P"":&O? WP/\._ W[/WQ(UC4M*^+&J?LO\
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MJ)_XFQ_XF_'!KW[]KGP?\%O '_!0'5?CA\./VR?$G[*W[3'BGX7^&/"WQ?\
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$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>form424b5_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b5_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  )\# 2(  A$! Q$!_\0
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M75[X4T^_O;N6XN+F+>[.1C)/8#I70TI+E;147S13[C=B_P!T?E63KZJ(+7
M_?\ I_L/6Q61K_\ J+7_ *^/_9'HCN*?PLGT'_D7=,_Z](O_ $ 5H5A:+J^G
M1:%IT<E[ CI;1JRLX!!"C(-7O[:TO_G_ +?_ +^"G*+N] C)<JU,"S\/SZ!X
MUU#5[:-I[+4U!F5/OQ2 YSCNIY^E=,LDLTJ[4:.-3EBXP6]L>E0?VUI?_/\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>form424b5_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b5_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  )\# 2(  A$! Q$!_\0
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M?_M[?M5^$_@8^LW/A[P;86-[XP^)6O61"ZC9^"-(*XBT9^D>K>('']E^<>(
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M*S-(SK\N9'8R,RCL"[$J/0@#'&/T_P#^"1=AXGLO^"@?[.?Q#T[5;/PSX/\
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MP6^&^YSI-H68GPKIN6+&$EB3DDDEF8LS$LQ)^C!X?T#)_P")'HV<=?['L\]
M?^>'Z]*\'_9"_P"34?V</^R*_#;_ -133:^E #D\=4'7IT'>OX-Q=6I]9QJ5
M2HOWE:S]I45G[6JKJU3S/]+,%1H_4,O_ '-+^%2O^YI:KV,-'^Z.>/AW1&)'
M]BZ,4V$ #1[$X/3IY!(]^?P%+_PCVBJ0?[&T<*$ V'2;(98?Q<P@]<'..M?D
MA\+?VO\ QC^UW_P42^/_ .S5X,U:]\(? ;]DCP_IUMXSU+1_]&\2?$/XK:Q=
MF!M+.H_ZW1_#_AU$N"L<:_\ $ZDPW")E?K+Q[:_M&>%/VAOV=K/P5XDBU?\
M9UU75/%^E_%O3=7L?MWB^TU-M O+[PA=1:QC*Z"-2@:.YW ,CFU0DJV3TUL'
MC</76'Q,YPDZ$*_*Y5+J%2DJL+VJ?'*#3LG=.5F[GGT,VR[&89XK"4(34<5+
M)+JC2LJM.IR.:2I.T(3T4N5Z:K0^P_\ A'M (!.AZ,>__('M#S[XAZC/M33H
M&@=3HNC$>ITBRR.>P,(S@CU)%6KFZAL;>>ZN9?)MK6V>[N9SP!&B%F/)X& >
MGT[U^1W[,_[9OQ/U/_@H3^TM^R/\?H;+1XM:T/0?C+^RNB 1C5/A6MH-*UNP
M=S@R:U'=1C5)(E9VC0W>X +BLL-@\?CL+F6)PTYM97#GDG5J<TTY13Y8NIS3
MY%)2FTFH0M)M7-L?F>7Y9BLKPN+I4E+-ING!^PI-1DH.2YG[*T.9KEBG).4W
M9)VL?K,?#^@-@_V'HW Z?V19'C\8#QVX(^E T#06'RZ'HQ/H=(L^.PS^X_/\
M,4:SIZ:QI5]IXO+W3UO+1X1>:;<&VO[7<#ME@E .R1205;!!Q@@@YK\+_P#@
MFC\8/B_\9?BY^WS\/?C=\?/%OBO1/@#\?)/ OPYN;J]TOP]J>F^%?)O9 -3F
MLK>)-19&5 EQ)N0*@W<G-;X#!XC'83,L7&M.,<I]E[9.5>4I*K.-.-N6I;XV
MU)RV2OW,<QS/ 97F>58.5"D_[9=14W[.@HITH.HV_P!RK)QM;76]KW:O^Y9T
M+0@RK_86B,<X;_B4V9,9QG!_<?*3Q@?CR<TO]@Z&2X_L'11R ,Z39@.=N<9\
MCYCR>/<&OQW_ ."<W[5OQ\^,W[37[;OP/\9W8^*?P2^!'C6'3?A#^T!;:2FF
M)K:W&W[3X*O=0M%32?%6J^'_ )UFUNT $FPB0E\UQ/\ P5;^)_Q^^$7QP_8*
MT_X.?''QG\.-%_:._:!TWX0_$K0=/ATV^TY_#3QVDSZGHS:A:2-I.M%"T3R(
M^'$C%3D$'JCDF->9QRI5Y>UE35=-5JSC9X5YLI:5;V]BG!P=FK.#VL<$^*L!
M#(?[>>4I4_:.BJ;H8=3TSS^Q;-NB_=Y_?7V94[22LTS]PAX?T$XSH>B C@?\
M2BS.2>N/W!_3J*1O#^A9 70]%XZYTBS&?8@P'&/:OG+]J2#XF^&?V6?BO:?!
M7Q#>V7Q6L?!%QIW@+Q#J"_VE?6?B*=X;2QU>X4*#<21F5[ALK@LF-H Q7Y!?
MMS>/?VI/V-?AI^P%X>T[]I3QOXH\>_%C]I3X9_#KXS^,-7@T\OXLTS78(GUW
M2]*TY+(Q:1!)*TD5N4PZQ+N8^8<##*LMGFE6-.AFCYYU*L*<9RK2YO94YU9R
M?+/W(J,9)*3OSI1L]UU9QG5+)*+Q6*RF#IV@I<L,-RKVDXTXJ[HM2?--/311
MNVUI?^@O^P= R,:+HH)Z+_9-F-W_ ) R?8 Y_4U&-!T') T'12<\ Z39<<\D
M?Z..<#CK^E? ^E?#K]HWX:_MP:!J<?QG\4^,OV8OB-\.O$_G?#CQ-#IU\?!7
MQ+TN6PETR31]8CM$U0:/=:;]K;RI9"JSDABX4$_4/QXU[QWH_P )/'\OPOBM
M[GXKWWA;7;'X9VMZ0+6\\9+I%]-I&_ P4BFB^VNK'#)%L)RV#QUL'5>)P"IY
MG.4*BBVE4JQC-SFX6JIU+Q<&FYK1<NJ=K7[*..I?5<RQ>)RNG3657;C[*A*4
MTJ<:EZ?+0;ES*7N\EV]FKZ'K8T#0,?\ ("T;Z'2+,8'X0_I_(T@T+0".-#T7
MCKC2;,D'T_U';MCK7YY?\$NOVN=6_; _92\)^-?'+?9OC)X#O]:^%WQRT9HS
M:7FF?$WP;=RZ9K!ET\YD@BU8*FJ0;@H=904R%X[3_@HQXA\<^"?V.?CG\3OA
M?X[\1_#GQY\-_AYXB\7^&=?T*.TG$>J:/;&:(:EIM^K0:C;E4(:.3:&R&4YX
M/1_9^/P^:2RK$59QJ^V5!2E4JNTY2BHJT:BE*,HSA)-7]R2>NQSK-<OQ.1/B
M#"TZ3RU4I5I?N:*ERP4G*Z]E92A*$XR4HIIIIM;GVTN@Z"P#?V'HV.G.DV9_
ME#GZ8P/7G-)_PC^A8(_L31B>,?\ $GLO?/\ RPY/^>]?GS_P2Z\3?$/XD_L5
M_ ?XR?%?XB>)/B)X_P#BCX)M?$?BC5]8:T@L#J.I7,C?\2K3-/18M.B"*J)&
MI8I\V[& !^CQ<J93N^X%'7H,@8[?GQG%88VE6P.*QF&=>=1T)R@W[2JHJ=.7
MLY64JK<5SWZJZLU:YW9?5H9CEF78R-"E&.:4X58KV5%M0DG)6M15G9*]D[71
ME'P_H&X8T/1N>_\ 8]H.#_VQR<^QYKY(_:XTO2[3P]\.FL[#2[%SXZNAYL.F
MVT;@#P;XERJM%%&Z[@<-M8!A@," *^T>I0CD87GMZ]?IS7QM^V%_R+?PY/;_
M (3Z]Y_[D_Q+1@JE5XNE>I4:]I!6=2HUKSZ6=1KIM;Y$9O0I+*\Q:I4DU3?*
MU1I)IWIZIJDG?3=-/S.U_9! ;]E3]G(/P%^"OPWQGC@>%=-'?V KZ2R1E57@
M#()SU X)'IZCT]R#7P)^S!^T)\#M"_9M^ V@:_\ %;P5H.LZ+\)_ NE:GIVJ
M:_I]MJ%CJ.F>'+"/4=/U!&D'E21,N'4JI9LLN01GZ '[4/[._ 'QF^'VWJ&_
MX233N1V_Y:?R/\\U6,P&-CBL=?+JUX5:C<?9U%_R]J-*3Y+12LK-NS7*T[.Y
M6"QV"EEN7R68TVI4X1YE*&MJ5-/6_>[VT:::NM/SN^&?['OB_P#9#_X* ?'C
M]IGP)HU[XV^#'[7&DZ;-\0M+TDF7Q?\ #7XF:3=^?%K*638&M>$?$2/<H^TK
M-HLV?O1L-WZ?V>I^(O%&J61LM.U'0/#^GW'GZA=ZO!]FU'5G0-MTZ&Q8$KIY
M# O.S!CM4*..>1/[4'[/*<K\9_A^QX_YF73?_CG(SV)_+/(/VH?V>GSO^,WP
M^';_ )&/3?Z2_P!>.36^+JYKCE'$8K+JTIPI4Z/M7&HN:%*$:=-RM#D<U!*-
M[KFY4VN:[?%@*&59<WAL)F,%SU)5'#FINTIR<Y6U;2<G=:-J[2E9JWF_[3_C
MWXE:%;>"O!7@+X*>-_BG8^./$>G:;X_U_P (7UAIR^ O GVS_B9ZR)-1N%_M
M34XE55CTN++M"9&(R #^=?\ P4U_9K^,=U\3OV1/VG?V3/ /C#Q_^T!^SSX^
MTVWN],AO;'3++Q#\&-;!3QCX6US5[X(3(+8EXH06;S+AD&#BOU;/[4/[/2LH
M7XR_#YASDCQ+IP YQ_ST!Y[X'/;% _:>_9X4,1\:?A\V2#M_X273N.3_ --.
M>ON>.<5T9?B,SRVO'$X;+:DHN%2,XRI5'3JQJ0E3DJD?9/3DF[IRBFMVSGS?
M 95GF'QV%Q69I.,J<E.$Z<9T73E&<7!\R:?-%-/1IW:MJ=WHOB^34? =IXUN
M_"WB/3+N31DO;KPC<V0;Q%9SF-1+I7V($++,DNZ-'#8D $@.TG'X<_\ !-;X
M ?%SP/\ M&?MUZW^T+^S1XF\+^&?VB?C<WQ!^&?B#6CHNKV;^%S'=QG3-:73
M+QFTB5?]%E6&53YF[:_4U^Q9_:B_9Z!R/C+\/S[GQ)IOT_YZ?XTK?M0?L\8.
M/C-\/CGJ!XETX?\ M0?_ %NGM1@<3F>#PF:X3"Y74MG*A&37UAR4:57VL5#D
MB^;WTE-OF<H>Y)M7)S#"93F6)RO%XK-*=\CNXV]C:4I4XTVYOI>*325E&5I1
M29ZIX=\->'/"6DIHWA?0-&\,:3;L\D6F^'],LM,T_>_^LE%GI\<*-(YY:0J7
M9CN9R1FOQ"_X*M?"S]H/XQ?'O]A+4/@S\"O&/Q%\/_LW?';3OB[\1]?M;W3M
M/TZ+0XX[6/\ LW15U"[0ZOK04/*8@,1JI56)R1^LQ_:@_9Y./^+R_#_CT\2Z
M:"/;_6?RJ4?M0?L[D 'XS_#X = ?$FFG'''_ "T_#KP?3-8977S3+L6L;++:
MDI14U%35:4??ISI2;:CS/W)RBDWI>_V4=&;8?*L[RV64_P!I0C&3A)^S=)2?
M)4A5C[J44DI03T6ZOHW<]7T?4D\0:-I^IRZ9?:>=1LTN6TO5[;[/?6C;06@U
M"$EU216^7 W+D @]*_#7_@KA\,_C_P#M#:W^R#9? OX#>./'T7P-_:3\*_&/
MQW?&73]#L(_#'A>3;+8Z2^HW:?VOK$N=\,2+@K&2I)? _7%_VG_V>#G/QG^'
MQ)/7_A(]-Z#L09>1^GY4H_:B_9YQ@_&;X?D>A\2::>G3GS ?RQ3RG$8S+,R6
M-PN62G*/.XIJHXIU(5*;O&,.:5HU9+WE=M)O706>X7*L[RQY3B\S@DW3<I*<
M%-NE*E-.S=DW*DG=/NNYZ7X3\3+XLTN+5CX=UK0)T2,-:^(]-^Q7T3/$I<*N
M]\!&RC[6 ?;TP0#\I6?C#XC_ !&_:8U+PQJ_PJ^(7@OX5?#_ ,.2/X)^*;7E
ME8Z/XO\ &EV^W6HI-(+R:BNGV^G%$T:Y8*LK?;@ZIN6O8C^U#^SSG)^,_P /
MS_W,NFD>AX\W'^<^E*?VHOV>?^BT?#TD<C_BH]-(SC_?KGI4,71E*7]G54Y<
MW*W"I[CDV[KFI23?^)-6NK:W7?5K8.M!169P48QBFE*.O(DM;26Z5WUO;6R5
M_P D?@9\'/CA^RI_P4Y^/'BSX8_!OQ[K'['W[4FF67B+QYJ'G:>L?@3XWZ1F
M.;Q-H^F&[$NHZ#XEA!^TR1HCI+/O96"8/WG_ ,%&]$\>>-?V-OCI\,OAC\/O
M$GQ&\??$WX>>(?"/AK0-#>SMT.I:O;".,ZGJ=^RP:7"-Y8RL&"D;5!QD>[G]
MJ']GM54CXR_#TGY<)_PDFGC:,G//F@>F,'U-,'[3_P"STKA1\9OA\4;<SO\
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-O"UM6V^R5[Z]KG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>form424b5_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b5_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 CX# 2(  A$! Q$!_\0
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MY[IK]FFD5H)B?+4?PXK-JQHG='$>$)[CP=XJF\)7DC-9RYDLF<]!Z5Z<217
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MAC1H]"\/6FGJH)1!N..I[TUI%ON#:<K'/^-?&K^'X+>>UB,GF/AD88K3\/\
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MGBN1>^[GU\[Y?04)2^(!J&MCY1J\(3TXKF;_ ,)/J-_+=RZG%YDG) (KL_\
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M_:!MD-T!CS,<TT:/IXU#^T/LL?VH_P#+7'-%% %T=Z1XDEC:-U#(PP0>]%%
M%6QTJQTM&2RMDA#G+;1U-2W5I!>V[VUS$LD3_>5NAHHH J6.A:9I;YL[..)L
M=0*T<444 %+BBB@!*6BB@!*6BB@!.] '%%%  !2XHHH *2BB@!11110 8I.U
;%% !2]J** $I:** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
